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ABSTRACT 
The technique of site-directed mutagenesis, including 
oligonucleotide-directed mutagenesis and cassette 
mutagenesis, enables us to make any possible structural 
alterations at desired sites in proteins whose genes have 
been cloned. This technique when combined with biochemical 
and X-ray crystallographic analysis has been proved to be a 
very powerful tool for studying the structure-function 
relationships in proteins. Using this technique, I have 
studied some functional requirements of RTEM-1 beta-
lactamase and the structure-function relationships between 
beta-lactamases and D,D-carboxypeptidases. 
Beta-lactamases can catalyze the hydrolysis of the 
amide bond in the beta-lactam ring of penam and cephem 
antibiotics. The precise catalytic mechanism of these 
enzymes is still unclear; the specific amino acid residues, 
in addition to the active site Ser, involved in binding or 
catalysis remain unknown. 
In Chapter I, to study the role of a conserved residue 
71, Thr, of RTEM-1 beta-lactamase, I have changed this 
residue into Ile, Leu and Met, 
oligonucleotide-directed mutagenesis. 
respectively, using 
The results indicate 
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that although the Thr residue may not be directly involved 
in binding or catalysis, both the methyl and the hydroxyl 
group on the beta-carbon of Thr71 play a very important 
role in stabilizing the conformation of the wild-type RTEM-
1 beta-lactamase; in this regard, the methyl group seems 
more important than the hydroxyl group. 
It has been proposed that beta-lactamases may have 
evolved from D,D-carboxypeptidases. Recently, structural 
data became available for comparing a penicillin-binding-
protein (or a D,D-carboxypeptidase) from Streptomyces R61 
with class A beta-lactamases from B. licheniformis 749/C 
and B. cereus 561. The significant similarity found by X-
ray crystallography in the spatial arrangement of the 
elements of secondary structure in these proteins strongly 
supports the hypothesis described above. Interestingly, 
there are conserved triads for both class A beta-lactamases 
and D,D-carboxypeptidases in the immediate vicinity of the 
active site Ser; the one for class A beta-lactamases is 
Ser-Thr-Xaa-Lys; however, the one for D,D-carboxypeptidases 
is Ser-Xaa-Thr-Lys. 
In Chapter II, to further study the roles of residues 
71 and 72 of RTEM-1 beta-lactamases and to study the 
possibility of creating a substantial D,D-carboxypeptidase 
activity within the background of beta-lactamase structure, 
I have changed the diad Thr71Phe72 of RTEM-1 beta-lactamase 
into Thr71thr72 and the D,D-carboxypeptidase-like 
vi 
sequences, Leu71Thr72 and Ile71Thr72. The results indicate 
that although these two residues may not be directly 
involved in binding or catalysis, they may play a very 
important role in keeping the active site Ser and the 
conserved Lys residue in the correct orientation for 
efficiently catalyzing the hydrolysis of the beta-lactam 
antibiotics by beta-lactamases. Moreover, none of these 
mutant beta-lactamases shows detectable D,D-
\ 
carboxypeptidase activity, suggesting that I may have to 
change more than two amino acid residues around the active 
site Ser of RTEM-1 beta-lactamase to generate a mutant 
beta-lactamase which can catalyze appreciable D,D-
carboxypeptidase activity. 
In Chapter III, to further study the structure-function 
relationships between beta-lactamases and D,D-
carboxypeptidases, I constructed a hybrid protein by the 
replacement of a polypeptide chain containing 29 amino acid 
residues (from residue 47 to 75, in the number system of 
Ambler) of RTEM-1 beta-lactamase with the corresponding 
sequence containing 30 amino acid residues of PBP-5 of E. 
coli. The results indicate that beta-lactam antibiotics 
can not only induce the catalytic activity of this hybrid 
protein but also stabilize the conformation of this 
-3 
protein. The purified hybrid protein shows about 10 of 
the specific activity of the wild-type beta-lactamase 
against benzylpenicillin and, interestingly, given the 
vii 
objective, this hybrid protein also shows about 1.8% of the 
D,D-carboxypeptidase activity of the wild-type PBP5 of E. 
coli. Furthermore, this hybrid protein shows no detectable 
transpeptidase activity, suggesting that the alpha-G helix 
in D,D-carboxypeptidase may play an important role in the 
transpeptidation reaction. 
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NOMENCLATURE 
The one-letter notation used is that recommended by the 
IUPAC-IUB Commission on Biochemical Nomenclature A, 
alanine; c, cysteine; D, aspartic acid; E, glutamic acid; 
F, phenylalanine; G, glycine; H, histidine; I, isoleucine; 
K, lysine; L, leucine; M, methionine; N, asparagine; P, 
proline; Q, glutamine; R, arginine; s, serine; T, 
threonine; V, valine; W, tryptophan; X, unknown or other 
amino acid; Y, tyrosine. 
Expressions of the form T71I indicate that a mutation 
that replaces threonine at residue 71 with isoleucine has 
been introduced. Expressions of the form T71I, F72T 
indicate that a double mutation that replaces threonine at 
residue 71 with isoleucine and phenylalanine at residue 72 




One of the most basic and interesting areas in protein 
biochemistry is to discover how structure at the molecular 
level is related to biological function. The utilization of 
the technology of protein crystallography and other 
physical techniques such as nuclear magnetic resonance, 
electron spin resonance, and circular dichroism, etc. has 
provided many insights into the structure-function 
relationships in proteins. However, since we can apply 
these techniques only to naturally occurring proteins, 
chemically modified proteins or mutant proteins obtained by 
random mutagenesis, many aspects of these problems could 
not previously be studied. When, however, one can generate 
structural variants in proteins at will, rational studies 
of these problems become possible; much more valuable 
information for discovering the basic principles that 
govern the structure-function relationships in proteins 
becomes available. Eventually, it may become possible to 
design new proteins that have novel and useful functional 
properties. 
With the advent of the technology of molecular biology 
and the development of the oligonucleotide synthesis, it 
has become possible to do site-directed mutagenesis on 
cloned genes. When applying this technique on genes that 
encode proteins, one can generate any possible structure 
variants at any residue in those proteins. 






mutagenesis and oligonucleotide-directed 
have been described. Cassette 
replacement of a short segment 
mutagenesis 
of a gene, 
unique restriction endonuclease sites with a 
synthetic mutant oligonucleotide duplex. Conveniently 
located restriction endonuclease sites may be present in 
the gene in its wild-type form. Alternatively, they may be 
introduced by oligonucleotide-directed mutagenesis. There 
are two general approaches for oligonucleotide-directed 
mutagenesis. The first uses single-stranded circular DNA 
vectors of the Ml3 or fd filamentous phages and the second 
uses double-stranded circular plasmid DNA vectors. Both 
approaches have their advantages and disadvantages. The 
site-directed mutagenesis techniques have been extensively 
reviewed (1, 2, 3,). 
The site-directed mutagenesis technique was first 
applied on studying the structure-function problems in 
proteins in 1982 (4, 5). Since then, this approach has 
been applied to many enzymes including tyrosyl-tRNA 
synthetase (6, 7), trypsin (8), dihydrofolate reductase (9, 
10), alkaline phosphatase (11), lac carrier protein (12), 
cytochrome c (13, 14), aspastate transcarbamoylase (15), 
triosephosphate isomerase (15, 16), lysozyme (17, 18), 
subtilisin (19), and beta-lactamase (20, 21). 
Using the technique of site-directed mutagenesis, I 
have studied some functional requirements of RTEM-1 beta-
4 
lactamase and the structure-function relationships between 
beta-lactamases and D,D-carboxypeptidases. 
Beta-lactamases catalyze the hydrolysis of the amide 
bond in the beta-lactam ring of penam and cephem 
antibiotics, producing acidic derivatives that have no 
antibacterial properties. They are the major determinants 
of the resistance to beta-lactam antibiotics of most 
bacterial pathogens (22). Based on amino acid sequence 
data and enzymatic analysis, these enzymes have been 
classified into three groups, class A, B and c. Class A 
bata-lactamases that have molecular weights of around 
29,000 show significant amino acid sequence homology among 
themselves (23, 24), and preferentially hydrolyze penam 
antibiotics. This group includes the RTEM-1 and RTEM-2 
beta-lactamases, as well as those of s. aureus PCl, 
Bacillus licheniformis 749/C, and B. cereus 569/Hl. Class 
B beta-lactamase is a metalloenzyme of molecular weight 
23,000, which attacks cephem antibiotics and is produced 
only by Bacillus cereus (23). Class c beta-lactamases are 
chromosomally determined cephalosporinases of E. coli. 
They are larger proteins (mol. wt. 39,000) and share no 
sequence homology with the class A beta-lactamases (25, 
26). The crystallographic structures of the class A beta-
lactamases of B. licheniformis 749/C (27) and B. cereus 569 
0 0 
(28) have been solved to 3.5 A and 2.5 A resolution, 
respectively. The precise mechanism by which beta-
5 
lactamases catalyze the hydrolysis of beta-lactam 
antibiotics remains uncertain, although there is 
considerable and persuasive evidence that the reaction 
intermediate is an acyl-enzyme (29, 30, 





catalysis, in addition to serine-70 [in the numbering 
system of Ambler (23)], are still unclear. In this work, 
the role of the conserved residue 71, Thr, of RTEM-1 beta-
lactamase has been studied by oligonucleotide-directed 
mutagenesis. 
Penicillin-binding proteins (PBPs) are defined as those 
bacterial proteins that bind penicillins and other beta-
lactam antibiotics covalently. These enzymes can catalyze 
the final polymerization and cross-linkage of peptidoglycan 
(33, 34). In a given organism, PBPs are numbered in order 
of decreasing apparent molecular weight, which usually 
ranges from molecular weight 140,000 to 40,000. In 
general, high-molecular-weight PBPs (mol . wt. 60,000-
140,000) are usually minor components, do not catalyze D,D-
alanine carboxypeptidase (CPase) or transpeptidation 
reactions using model substrates, and are often essential 
for cell viability (34). By contrast, the low-molecular-
weight PBPs (mol. wt. 40,000-50,000) are relatively 
abundant, catalyze D,D-alanine carboxypeptidase reactions 
in vitro and appear to be unnecessary for cell viability. 
Most PBPs are membrane proteins. Several exocellular D,D-
6 
carboxypeptidases have also been purified and 
characterized, such as the D,D-carboxypeptidases secreted 
by Antinomadura R39, Streptomyces R61 and Streptomyces 
albus G (35, 36, 37). The crystallographic structure of 
the D,D-carboxypeptidase from Streptomyces R61 has been 
0 
solved to 2.8 A resolution (38). 
The interaction of CPases with acyl-D-alanyl-D-alanine 
substrate is best described by a three-step mechanism (34). 
Enzyme E and substrate S first react to form a noncovalent 
complex E.S .. In the second step, a covalent acyl-enzyme 
intermediate E-P forms, with release of the terminal D-
alanine. Reaction of E-P with either H O or RNH 
2 2 
regenerates free enzyme with formation of either the CPase 
product (P-OH) or the transpeptidase product (P-NH-R) (34), 
respectively. 
The interaction of CPases with beta-lactam antibiotics, 
however, leads to the formation of a relatively stable 
covalent acyl-enzyme intermediate. By the formation of 
this intermediate, the antibiotics essentially inhibit the 
CPases irreversibly. It has been proposed that beta-lactam 
antibiotics bind to and inactivate these CPases by virtue 
of their structural similarities to the acyl-D-alanyl-D-
alanine substrate (39). It has also been hypothesized that 
beta-lactamases may have evolved from penicillin-
sensitive enzymes by developing an efficient catalytic 
mechanism for hydrolysis of the penicilloyl-enzyme 
7 
intermediates ( 3 9) • The recent discoveries of the 
significant similarity between the three-dimensional 
structures of R61 D,D-carboxypeptidase and the class A 
beta-lactamases of B. licheniformis 749/C (27) as well as 
B. cereus 569 (28) strongly support the hypothesis 
described above. 
In this work, to further understand the role of residue 
71 and 72 of RTEM-1 beta-lactamase and to study the role of 
these two residues in the structure-function relationships 
between beta-lactamases and D,D-carboxypeptidases, I have 
prepared double mutants with D,D-carboxypeptidase-like 
sequences in the immediate vicinity of the catalytic 
serine 70. To continue studying the structure-function 
relationships between beta-lactamases and D,D-
carboxypeptidases, I have constructed a hybrid protein of 
RTEM-1 beta-lactamase and PBP-5 of E. coli In short, these 
studies are focused on the use of mutagenesis to study some 
requirements for catalytic function of RTEM-1 beta-
lactamase and the structure-function relationships between 
beta-lactamases and D,D-carboxypeptidases. 
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CHAPTER I 
STUDIES OF THE ROLES OF RESIDUE 71 
OF RTEM-1 BETA-LACTAMASE 
BY OLIGONUCLEOTIDE-DIRECTED MUTAGENESIS 
13 
INTRODUCTION 
Beta-lactamases can catalyze the hydrolysis of the 
amide bond in the beta-lactam ring of penam and cephem 
antibiotics (1). They are the major determinants of the 
resistance to beta-lactam antibiotics of most bacterial 
pathogens. Based on amino acid sequence data and enzamatic 
analysis, these enzymes have been classified into three 
groups, class A, B and c. Individual beta-lactamases vary 
considerably in their specificity toward different classes 
of beta-lactam antibiotics (2). These enzymes have not 
been found to hydrolyze acyclic peptides, involving D-Ala-
D-Ala. However, they can catalyze the hydrolysis of 
acyclic depsipeptides which are ester analogues of D-Ala-D-
Ala (3). 
It is believed that there is a covalent acyl-enzyme 
intermediate for the beta-lactam hydrolysis reaction by 
beta-lactamases (4, 5, 6, 7). The existence of the 
covalent acyl-enzyme intermediate can be observed directly 
by the use of a poor substrate cefoxitin (4), or trapped 
by the use of low pH or subzero temperature for good 
substrates such as dansyl-penicillin and dansyl-
cephalosporin (5, 8). Despite these findings, the precise 
catalytic mechanism of beta-lactamases remains unclear. 
The structural data of the class A beta-lactamases of 
14 
~ licheniformis 749/C (9) and !!.!_ cereus 569 (10) are now 
available. However, the relatively low resolution 
complicates detailed interpretation of these structures; 
the knowledge we have of the essential catalytic groups is 
still limited. Early chemical modification studies, 
reviewed in Ref. (11), implicated almost every type of 
amino acid with a reactive side-chain. These 
investigations dramatically illustrate the limitation of 
this approach. In fact, the only residue for which there 
is strong evidence of its functional involvement is serine-
70 [in the numbering system of Ambler (12)] . This residue 
is implicated by covalent modification, by inhibitors (13), 
by conservation of sequence homology, by analogy to the 
related D,D-carboxypeptidase crystallographic structure 
(14) and by site-specific mutagenesis (15, 16, 17). 
The site-specific mutagenesis experiments have been 
undertaken on the RTEM-1 beta-lactamase. Replacement of 
the active-site Ser by Thr (15) leads to the absence of the 
catalytic activity in the mutant. The replacement of the 
active-site Ser by Cys leads to reduced catalytic activity 
(16, 17) and a different substrate specificity to that of 
the wild type (17). This technique, which enables us to 
make any possible structural alterations at desired sites 
in proteins, has also been used for studying the 
essentiality of specific residues in catalysis for tyrosyl-
tRNA synthetase (18, 19, 20), alkaline phosphatase (21), 
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cytochrome c (22), aspartate transcarbamoylase (23), lac 
carrier protein (24), triose phosphate isomerase (25) and 
poliovirus 3C protease (26). 
In this work, I have focused on a conserved residue 71, 
Thr, of class A beta-lactamases. In the beta-lactamase of 
s. aureus PCl, replacement of this Thr residue by Ile gives 
rise to a mutant that shows no catalytic activity (12); 
however, a mutant of the RTEM-1 beta-lactamase of E. coli 
in which Thr 71 has been replaced by Ser still shows 
appreciable catalytic activity (27). To further 
investigate the role of this residue in class A beta-
lactamases, I have changed this residue Thr 71 of RTEM-1 
beta-lactamase into Met, Ile and Leu, respectively, using 
oligonucleotide-directed mutagenesis. Interestingly, cells 
that produce any of these three mutant beta-lactamases show 
appreciably resistant phenotype to both ampicillin and 
benzylpenicillin. The mutant proteins with the replacement 
of the residue Thr 71 by Met or Leu are too unstable to be 
isolated and further characterized. Mutant beta-lactamase 
with replacement of Thr 71 by Ile shows dramatic changes in 
the kcat and Km values against penam and cephem 
antibiotics. At the same time, the role of this residue 
Thr 71 had also been studied by the use of site-saturation 
(28). Combining all the results described above, we 
suggest that the residue Thr 71 might not be directly 
involved in catalysis; however, it does play a very 
16 
important role in stabilizing the conformation of RTEM-1 
beta-lactamase. 
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MATERIALS AND METHODS 
CELLS 
E. coli HBlOl cells containing wild-type or mutant 
beta-lactamase genes in pBR 322 were grown in LB media 
(29). Mutagenesis experiments were done in E.coli JM103, 
which was served as a host for phage Ml3mp8 (30) . For 
growth of plasmid containing the tac promoter, E. coli 
strain Dl210 was used as a host. 
q 
I derivation of HBlOl. 
DNA 
E. coli Dl210 is a lac 
Plasmid DNA was prepared by the alkaline lysis method 
( 29) • 
The plasmid pKK carrying the wild-type beta-lactamase 
gene under the control of the tac promoter was obtained 
from John Rossi. 
Sequence determination was done by the dideoxy method 
(31) on a 700bp EcoRI-PstI fragment subcloned into Ml3mp9; 
three synthetic oligonucleotides, 5' - CAT TTC CGT GTC GCC 
c- 3 1 , 5 1 - GTT GAG ACC GCG GCG - 3 1 and 5 1 - CAC AAC ATG 
GGG GGA TC -3', complementary to the insert were used as 
primers. 
ENZYMES AND CHEMICALS 
Restriction enzymes, T4 DNA ligase and T4 
polynucleotide kinase, were obtained from BRL, DNA 
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polymerase (Klenow fragment) from Boehringer-Mannheim. All 
antibiotics were from Sigma Chemical Co. 
MUTAGENESIS IN Ml3 VECTORS 
The methods for growth of phage, and purification of 
phage DNA or RF DNA for sequencing, mutagenesis and 
cloning had been described in detail (30). 





5 1 - G ATG AGC ATG TTT AAA G - 3 1 
5 1 - G ATG AGC ATT TTT AAA G - 3 1 
5 1 - G ATG AGC CTA TTT AAA GT - 3 1 
mutagenic 
Instead of using the Ml3 universal sequencing primer, I 
used a synthetic oligonucleotide (5 1 - G TTG AGA CCG CGG CG 
- 3 1 ) complementary to the insert at a site 50bp upstream 
from the sequence of interest as a second primer. The 
procedures used for the mutagenesis (Figure 1) are 
described below. 
Single stranded template DNA (0.5 pmole) was combined 
with 20 pmoles of a phosphorylated mutagenic primer and 20 
pmoles of the phosphorylated second primer in a 20 :mM tris 
buffer solution of total volume 12 microliters at pH 7.5 
containing 6mM NaCl, 8mM MgC12 and lOmM OTT. 
This solution was heated to 90oC for 5 minutes and 
allowed to stand at room temperature for 45 minutes. The 
synthesis of the second strand was initiated by adding 3.5 
microliters of a solution containing 7.5 nanomoles of each 
of the four deoxynucleotide triphosphates, and four units 
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of the Klenow fragment of ~ coli DNA polymerase I. After 
0 
this mixture was incubated at 15 C for 2 hours, 20 
nanomoles of ATP and 4 units of T4 DNA ligase (BRL) were 
added and the reaction mixture was allowed to incubate at 
0 
15 c for another 12 hours. The reaction mixture was then 
0 
heated to 65 C for 10 minutes. Aliquots of this mixture 
were used to transform E. coli JM103. 
SCREENING FOR MUTANTS 
When an adequate number of independent transformants 
had been obtained, positive colonies were identified either 
by dot blots or by screening filter replicas prepared on 
Whatman 541 filter papers. 
The synthetic oligonucleotides, used to direct 
32 
mutagenesis, were phosphorylated with gamma- P-ATP by T4 
phosphonucleotide kinase and used as hybridization probes. 
For doing dot blots, cells from sixty single plaques 
were transferred into 2ml of broth, respectively, and 
incubated for 6 hours with good aeration, the cells were 
centrifuged and 3 microliters of each supernatant were 
spotted on dry, untreated nitrocellulose filters and baked 
0 
for 90 minutes in a vacuum at 80 c. Prehybridization was 
done at room temperature for 30 minutes in a solution 
containing 0.2% SDS, lOX Denhardt's (29), O.l mg/ml 
sonicated and denatured salmon sperm DNA, l mM sodium 
orthophosphate, l mM sodium pyrophosphate, 0.5 mM ATP and 
6XSSC buffer. Then the nitrocellulose filters were 
20 
hybridized for at least 2 hours at room temperature in a 
solution containing 0.2% SDS, lOX Denhardt's, 0.25 mg/ml 
yeast tRNA (Sigma, phenol extracted), 1 ~ sodium 
orthophosphate, 1 ~ sodium pyrophosphate, 0.5 ~ ATP, 
6XSSC buff er and 1 to 2 ng/ml of the labeled 
oligonucleotide. 
The filters were washed in 6XSSC, three times for five 
minutes, and then at 1 to 3 degrees below the estimated Td; 
autoradiograms were taken after each wash. 
The plaques carrying mutant phage can also be 
identified by hybridizing the mutagenic oligonucleotide, 
32 
labeled with P, to filter replicas that are prepared on 
Whatman 541 filter papers. 
Whatman 541 filter replicas were first prehybridized in 
6X SET, 0.5% NP-40 (Sigma), 100 mg/ml deproteinized, 
denatured salmon sperm DNA, 1 ~ sodium orthophosphate, 1 
0 
~ sodium pyrophosphate, 0.5 ~ ATP at 65 C for 2 hours. 
The filters were then hybridized for at least 2 hours at 
room temperature in a solution containing 0.2% SDS, lOX 
Denhart's, 0.25 mg/ml yeast tRNA (Sigma, phenol extracted), 
1 ~ sodium orthophosphate, 1 ~ sodium pyrophosphate, 0.5 
~ ATP, 6XSSC buffer and 1 to 2 ng/ml of the labeled 
oligonucleotide. Washing was done in 6XSSC, first at room 
temperature (3 times for 5 minutes each time) and an auto-
radiogram was made. Additional washes were done at 1 to 3 
degrees below the estimated Td for the oligomer; 
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autoradiograms were taken after each wash. 
After positive colonies were identified, the mutant 
phages were plaque-purified and characterized by DNA 
sequencing. 
PURIFICATION OF MUTANT BETA-LACTAMASE 
The isolation procedure was basically that in the 
literature (27). 
~ coli strain Dl210 containing mutant RF DNA was grown 
to late log phase in ten liters of XB medium (25g tryptone, 
7.5g yeast extract, 50 ml of lM Tris-HCl, pH 7.5, 15mg 
ampicillin/liter) in a New England Biosystems fermenter 
0 
with vigorous aeration at 30 c. The cells were collected 
by centrifugation and resuspended with l liter of 50 mM 
Tri-HCl buffer, pH 7.0. IPTG was then added to lmM. After 
0 
4 to 6 hours at 4 c the cells were collected by 
centrifugation. The osmotic extrusion was done as 
described ( 27) • Solid ammonium sulfate was added to the 
supernatant to reach 20% (w/v). After being stirred for 12 
hours at room temperature, the ammonium sulfate solution 
was centrifuged; and the precipitate was collected and 
discarded. Additional ammonium sulfate was added to the 
supernatant to reach 60% (w/v). After being stirred at 
room temperature for another 12 hours, the ammonium sulfate 
solution was centrifuged at 16,000Xg for 45 minutes; and 
the precipitate was collected. This precipitate was 
redissolved in distilled water and the insoluble portion 
22 
removed by centrifugation at 10,000xg for 20 minutes. 
Activity recovered from the ammonium sulfate precipitation 
step was 80% to 100%. After removal of the ammonium 
sulfate residue by dialysis against 25 mM triethanolamine-
HCl, pH 7.25, this solution was concentrated to 5 to 10 ml 
and applied to a 2.5 X 30cm DEAE-cellulose (DE-52) column 
equilibrated with the same buffer. The column was developed 
using a linear triethanolamine-HCl gradient (25 to 200 mM, 
pH 7.25). The active fractions were pooled and 
concentrated to 2 ml by ultralfiltration and applied in two 
equal portions to a 1 X 90 cm column of Ultragel 54 and 
eluted with 20 mM Tris, pH 7.0. About 10 to 15 mg of pure 
protein can be isolated from a 10-liter culture, 
representing an overall yield of approximately 23% to 35%. 
Only 1 - 3 mg of Ile71 mutant beta-lactamase and about 100 
µg of Leu71 mutant beta-lactamase could be isolated by this 
procedure from a 10-liter culture. 
ENZYME ASSAYS 
After purification, the purity of mutant beta-
lactamases was checked on 12% SDS-PAGE. Protein 
concentrations were determined according to the published 
-1 
conversion factors, 29,400M , and the absorbance at 281 nm 
( 3 2) • Protein activities were determined by measuring the 
change in absorbance with time at a specific wave length. 
0 
All measurements were done at 25 c in 50 mM potassium 
phosphate, pH 7.0, using a Beckman Acta CIII with 1 cm path 
23 
length cells. Hydrolytic cleavage of ampicillin was 
observed at 235 nm, 
cephalothin at 260 nm. 
benzylpenicillin at 240 nm, 
-1 




for benzylpenicillin {32), 
-1 -1 
1875 M cm for ampicillin and 
-1 -1 
7,700 M cm for cephalothin (4). 
THERMAL STABILITY 
Purified mutant beta-lactamases (0.1 mg/ml in 0.1 M 
pH 7.0) were incubated at the potassium phosphate, 
indicated temperature. After the various times indicated, 
aliquots of samples were removed and immediately assayed at 
0 
30 c in 1 mM potassium phosphate buffer, pH 7.0, for 
remaining activity using benzylpenicillin as substrate. 
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RESULTS 
Residue 71, Thr, of RTEM-1 beta-lactamase has been 
specifically changed into Met, Leu and Ile, respectively, 
by the use of oligonucleotide-directed mutagenesis. Table 
1 shows the mutagenic primers used for directing each 
mutation. The scheme for two-primer mutagenesis is shown 
in Figure 1. Two methods have been used for screening the 
mutants as described in Methods and Materials. The 
autoradiograms obtained by screening the mutants with the 
32 
P-labeled mutagenic probe directing the change of 
Thr71 of RTEM-1 beta-lactamase into Met are shown in 
Figure 2, 3a and 3b. The final wash temperatures for each 
screening are shown in Table 2. The efficiency of 
mutagenesis is about 3% to 5%. For checking the 
resistance phenotypes of these mutants against beta-lactam 
antibiotics, the mutagenized genes were cloned back 
into pBR322. HBlOl was used for growth of the plasmids 
containing the mutagenized beta-lactamase genes. For 
production of the mutant proteins, the mutagenized genes 
were cloned into the pKK plasmid containing a tac promoter. 
The tac promoter can be induced by IPTG; the host used for 
growth of these plasmids is E. coli Dl210, which is a lac 
q 
I derivative of HBlOl. 
The conditions for the induction of the tac promoter 
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for the production of beta-galactosidase by IPTG have 
previously been studied (33). The induction becomes 
optimal after 2 hours by the use of 1 mM IPTG. However, 
this condition can't be used for inducing the production of 
beta-lactamases since overproduction of beta-lactamase may 
cause the cells to become very unhealthy and the resulting 
purification of beta-lactamase may become difficult. 
Figure 4 shows that by the use of 100 mM to 200 mM IPTG, 
the induction will reach the optimal in 5 hours. 
For the unstable mutant proteins, the induction was 
0 
done at 4 c for 6 hours by lmM IPTG. The conditions for 
inducing the tac promoter for the production of the 
unstable mutant beta-lactamase have not been optimized. 
The T71M and T71L mutants of beta-lactamase were too 
unstable to be further characterized. The purity of the 
isolated mutant proteins was checked by 12% SDS 
polyacrylamide gel electrophoresis. Some catalytic 
properties of purified T71I mutant of beta-lactamase has 
been characterized. Table 3 shows the kcat and Km values 
of T71I mutant of beta-lactamase against benzylpenicillin, 
ampicillin, and cephalothin. Table 4 shows the differences 
between the thermal stability of the T71I and T71L mutants 
of beta-lactamase as well as wild-type beta-lactamase. 
26 
DISCUSSION 
IN VITRO MUTAGENESIS 
I have generated three single mutations at site 71 of 
RTEM-1 beta-lactamase using oligonucleotide-directed 
mutagenesis. Two primers were used; one was the mutagenic 
oligonucleotide and the other was an oligonucleotide that 
primes about 50 base pairs away. Each primer was extended 
on the same single-stranded template by the Klenow fragment 
of E. coli DNA polymerase. The reaction mixture was used 
directly for transfection without the isolation of 
covalently closed double-stranded DNA. Screening for 
32 
mutant phages was accomplished by the use of the P 
labeled mutagenic oligonucleotides as hybridization probes. 
The efficiency of mutagenesis is approximately 3% to 5%. 
The features of the mutagenic oligonucleotides used in 
this work are basically the same as described by Zoller and 
Smith (34). Generally, in making small changes of one or 
two bases, 17mer or 18mer can be used. Another thing 
that should be taken into consideration is the prevention 
of the self-hybridization of the mutagenic oligonucleotide. 
For example, 5 1 - G ATG AGC ATG TTT AAA is not suitable for 
directing mutagenesis because it tends to hybridize to 
itself; in the presence of the large fragment (Klenow) of 
DNA polymerase, double-strand oligonucleotides may be 
27 
formed. In such uses, the efficency of mutagenesis can be 
expected to be very low. 
Another factor that may affect the efficiency of 
mutagenesis is the position of the upstream primer. In 
this work, the upstream primer is a sequencing primer that 
extends upstream from a position 50bp of the mutagenic 
oligomer. The efficiency of mutagenesis is about 3-5%. 
When the Ml3 sequencing primer is used as the upstream 
primer that extends from a position 2.9kb upstream of the 
mutagenic oligomer, the efficiency can go up to 50% (34). 
In addition, another successful experiment has been 
completed in which the upstream primer is only 200 bases 
away; and the efficiency is around 1% (34). These 
differences reflect the proximity of the two 
oligonucleotides (34). 
Two procedures have been used in screening for the 
mutants. One is adapted from the procedure developed by 
Gergen et al. (35), with some modifications. This 
procedure is originally designed for screening colonies 
containing recombinant plasmids. In this method, Whatman 
540 filter papers are used to make replicas. With the 
modified hybridization conditions, this method can be 
successfully applied to screening for plaques containing 
mutagenized Ml3 phages. The results obtained by the use 
of the method described above are as good as those obtained 
by another method, the dot-blot hybridization {34). The 
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major advantages of the first method are that Whatman 540 
filter papers are cheaper, easier to handle and to store 
than nitrocellulose filter papers, which are used in the 
dot blot hybridization procedure. 
After the putative mutants are identified, the plaque 
purification procedure is essential because these original 
plaques may contain a mixture of wild-type and mutant 
plaques. Some investigators think that, theoretically, 
each original suspected plaque should contain a 50 50 
mixture of wild-type and mutant phage (34). When checking 
the life-cycle of Ml3, we can find that this is not true 
(36). Theoretically, in each original suspected plaque, 
the ratio of the mutant phage to the wild type should be 
larger than 60%. In practice, we found that most suspected 
plaques contained almost 100% mutant by analysis of plaque-
purif ied clones. Similar results have also been observed 
by other investigators (34). These observations indicate 
that the replaced parental (+) strand of wild-type Ml3 
phage can't be used as a template as efficiently as the (-) 
strand of the mutagenized Ml3 phage. 
currently, a number of relatively simple and reliable 
procedures for oligonucleotide-directed mutagenesis have 
been developed (37, 38, 39, 40). The choice of which 
method to use may depend simply on the familarity of an 
individual with the particular vector system and enzymes 
utilized with the method. 
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ROLES OF RESIDUE 71 OF RTEM-1 BETA-LACTAMASE 
All the cells containing these mutant beta-lactamases 
show significant resistance to benzylpenicillin and 
ampicillin, indicating that the residue Thr71 may not be 
directly involved in either binding or catalysis. The T71I 
mutant of beta-lactamase shows dramatic changes in the kcat 
and Km values against benzylpenicillin and ampicillin. 
Moreover, this single mutation has a stronger effect on the 
kcat/Km value against cephems than on the kcat/Km value 
against penams. Another mutant beta-lactamase with the 
replacement of Thr71 by Ser has also been purified and 
partially characterized at the same time (27). The 
differences in the thermal stability of these mutant beta-
lactamases are shown in Table 4. When comparing the 
differences in the structures of Thr, Ile, Ser and Leu, we 
can find that there are a methyl group and a hydroxyl group 
on the beta-carbon of Thr; there is a corresponding methyl 
group, but there is no such hydroxyl group on the beta-
carbon of Ile; in contrast, there is a corresponding 
hydroxyl group, but there is no such methyl group on the 
beta-C of Ser; finally, there is neither a corresponding 
methyl group nor a corresponding hydroxyl group on the 
beta-c of Leu. Combining the differences in the thermal 
stability of these mutant beta-lactamases with those in the 
structures between Thr, Ile, Ser and Leu, we conclude that 
both the methyl and the hydroxyl group on the beta-carbon 
30 
of Thr play a very important role in stabilizing the 
conformation of the wild-type RTEM-1 beta-lactamase; in 
this regard the methyl group seems more important than the 
hydroxyl group. 
The role of this residue has also been investigated by 
site-saturation (21). The residue Thr71 of RTEM-1 beta-
lactamase has been changed into all 19 possible amino acid 
residues. The results obtained by that study indicate 
again that the residue 71 is not directly involved in 
either binding or catalysis, and the same conclusion has 
been reached that both the methyl and the hydroxyl groups 
of Thr71 of RTEM-1 beta-lactamase play a very important 
role in stabilizing the conformation of the protein. 
31 
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TABLE I 
MUTATIONS AT THE SITE 71 OF RTEM-1 BETA-LACTAMASE 
mutation a.a. sequence DNA sequence 
None 
( ie • wild -type 
Met Ser Thr Phe Lys G ATG AGC ACT TTT AAA GT 
seQuences) 
* Thr71~ Met Met Ser Met Phe Lys G ATG AGC ATG TTT AAA G 
* The71~ Leu Met Ser Leu Phe Lys G ATG AGC CTG TTT AAA GT 
* Thr717 Ile Met Ser Ile Phe Lys G ATG AGC ATT TTT AAA G 
' 
* These are the exact DNA sequences of the mutagenic primers 









EcoRI 8 PstI 
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RF of M13mp9 
l digested with EcoRI 8 Pstl 









I. ligation, transformation 
8 isolation of ssDNA 
2. annealing with a mutagenic primer 
a a second primer at 95°C/5 min. 
3. primer extension a ligation 
( dNTPs, K le now, T4 I igase) 
4. transformation 
plaques 
screening for mutants by 
32P-labeled mutagenic probe 
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FIGURE II 
AUTORADIOGRAM OF A DOT BLOT 
The dot blot procedure used for screening mutants has been 
32 
described in the Methods section of this chapter. The P 
labeled mutagenic probe used here is 5 1 - G ATG AGC ATG TTT 
AAA G - 3 1 • The nitrocellulose membranes were washed at 
0 




Autoradiograms of Whatman 541 filter replicas of 
phage-infected colonies which have been treated according 
to the hybridization procedure described in the methods 
32 
section and washed at room temperature in 6XSSC. The P 
labeled mutagenic primer used here is 5 1 - G ATG AGC ACT 
TTT AAA G - 3 1 • The arrows indicate the colonies that may 
contain the mutagenized genes. 
' 
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FIGURE III-b 
AUTORADIOGRAMS OF WHATMAN 541 FILTER REPLICAS OF PHAGE-
INFECTED COLONIES WHICH HAVE BEEN TREATED ACCORDING TO THE 
0 
HYBRIDIZATION PROCEDURE AND WASHED AT 44 C. 






THE DNA SEQUENCES OF THE MUTAGENIC PRIMERS 
The DNA sequences of the mutagenic primers used to 
introduce mutations in the RTEM-1 beta-lactamase gene are 
shown as above; mismatched bases are indicated in bold-face 
characters, and the corresponding wild-type bases are shown 
below in parentheses. Td is the melting temperature 
estimated from the empirical relationship Td = 4X (G-C base 
pairs) + 2X (A-T base pairs) (41). The discriminating 
temperature is the wash temperature (in 6XSSC) at which a 
difference in hybridization was observed between a 
perfectly matched DNA duplex (oligomer/mutant) and the 
corresponding heteroduplex (oligomer/wild type). 
DNA sequence or mutagenic primers 
G ATG AGC ATG TTT AAA G 
(GC) 
G ATG AGC CTG TTT AAA GT 
(A) 















INDUCTION OF TAC PROMOTOR FOR PRODUCTION 
OF WILD-TYPE BETA-LACTAMASE BY IPTG. 
Aliguots of culture solutions containing different 
concentrations of IPTG were taken out and centrifuged. The 
pallets were resuspended in lOXTE buffer and centrifuged. 
Pallets were resuspended in cold water and centrifuged 
again. The specific activity against benzylpenicillin of 
each supernatant was then assayed. 
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COMPARISON OF CATALYTIC PARAMETERS OF WILD-TYPE 
AND THR?l -> ILE MUTANT BETA-LACTAMASE 
~ 
Km(µM) kcat(sec-1) kcat/Km(sec-lµM-1 ) 
~ 
Ampicillin 50(50) 145(2,000) 2.9(40) 
Benzylpenicillin 350(50) 1,530(1 , 700) 4.4(34) 
Cephalothin 1,250(250) 4.59(230) 3.7x10-3 co.92) 
* : wild-type value in brackets. 
. . Km kcat kcat/Km 
Ser?OThr?l(wild t~e) 0.2 
(benzylpenicillin cephalothin) 
7.39 36.9 
Ser?Oile71 0.28 333.3 1,189 
(benzylpenicillin/cephalothin) 
Ser?OThr?l{wild type) 0.2 8.70 43.5 
(ampicillin/cephalothin) 
Ser?Oile71 0.04 31.6 ?84 
(ampicillin/cephalothin) 
TABLE IV 




*S70T71 S70, T71S S70, T71I 
(wild type) 
40°c ------ 9 min > 30 min 
so 0 c > 30 min < 1 min 5 min -
55°c 13 min ------ < 1 min 
60°c 1-2 min ------ ------
*From Jim Neitzel's data. 
S70, T71L 
3 min 







STUDIES OF THE ROLES OF RESIDUES 71 AND 72 
OF RTEM-1 BETA-LACTAMASE 
BY CASSETTE MUTAGENESIS 
51 
INTRODUCTION 
There are two groups of bacterial enzymes that interact 
strongly with beta-lactam antibiotics, the beta-lactamases 
and the penicillin-binding-proteins. Both groups of 
proteins can be acylated by beta-lactam antibiotics, 
although only for the beta-lactamases is deacylation a 
rapid process (1). Beta-lactamases have not been found to 
hydrolyze acyclic peptides, involving D-Ala-D-Ala, which 
are model substrates for D,D-carboxypeptidases (2, 3). 
However, certain acyclic depsipeptides, analogous in 
structure to the terminal D-Ala-D-Ala moiety of the 
peptidoglycan cross-link, are substrates for both beta-
lactamases and D,D-carboxypeptidase (4). It has been 
proposed by Tipper and Strominger (5) that beta-lactam 
antibiotics are structural mimics of the c-terminal, D-
Ala-D-Ala, residues of the peptide chain of uncross-linked 
peptidoglycan. They have also suggested that beta-
lactamases may be evolutionary descendants of the 
penicillin-binding-proteins involved in peptidoglycan 
synthesis (5). Subsequent structural and mechanistic 
investigations have in general tended to support these 
ideas ( 6, 7 , 8 , 9) . 
Recently, structural data became available for 
comparing a penicillin-binding-protein (or D,D-
52 
carboxypeptidase) from streptomyces R61 with class A beta-
lactamases from B. licheniformis 749/C (10) and B. cereus 
569 (11). The significant similarity found by X-ray 
crystallography in the spatial arrangement of the elements 
of secondary structure in these proteins strongly supports 
the hypothesis described above. These results led us to 
study the possibility of creating a substantial D,D-
carboxypeptidase activity within the structural background 
of a beta-lactamase by mutagenesis. 
There is homology between the amino acid sequence 
around the penicillin-binding sites of the D,D-
carboxypeptidases and the sequence around the active site 
serine of the class A beta-lactamases (12). The specific 
amino acid residues involved in catalysis for both enzymes, 
in addition to the active site serine, are still unclear. 
Interestingly, both enzymes contain a conserved triad. The 
one for 
[residue 
class A beta-lactamases is Ser-Thr-Xaa-Lys; 
70 to 73 in the numbering system of Ambler (13)], 
however, the one for D,D-carboxypeptidases is Ser-Xaa-Thr-
Lys. The serine at residue 70 is the active site for both 
enzymes (3, 8, 14, 15). The lysine at residue 73 is 
conserved in class A beta-lactamases (13), class C beta-
lactamases (16) and all membrane-associated D,D-
carboxypeptidases (17). The role of this residue is under 
thorough investigation (18). The role of residue Thr71 of 
RTEM-1 beta-lactamase has been studied in Chapter I. It is 
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not directly involved in catalysis or binding; however, it 
may play an important role in stabilizing the conformation 
of class A beta-lactamases. 
Here, to study the possibility of creating substantial 
D,D-carboxypeptidase activity within a beta-lactamase 
background and to further study the roles of residue 71 and 
72 in the catalytic activity, substrate specificity and 
thermal stability of class A beta-lactamases, I have 
changed the diad Thr71Phe72 of RTEM-1 beta-lactamase into 
Thr71Thr72 and D,D-carboxypeptidase homology sequences, 
Leu71Thr72 as well as Ile71Thr72, by cassette mutagenesis. 
The mutant protein containing the diad, Leu71Thr72, is too 
unstable to be purified and characterized. The mutant 
proteins containing the diads, Thr71Thr72 and Ile71Thr72, 
were purified and partially characterized. The results 
indicate that the residue 72 of RTEM-1 beta-lactamase is 
not directly involved in catalysis; however, residues 71 
and 72 may play a very important role in keeping Ser70 and 
Lys73 in the correct orientation in beta-lactamases for 
efficiently catalyzing the hydrolysis of beta-lactam 
antibiotics. None of these mutant beta-lactamases shows 
detectable D,D-carboxypeptidase activity. This implies 
that some of the amino acid residues involved in binding 
or catalysis by D,D-carboxypeptidases may be different from 
those involved in binding or catalysis by beta-lactamases. 
54 
MATERIALS AND METHODS 
ENZYMES AND CHEMICALS 
Restriction enzymes and the large fragment of DNA 
polymerase I (Klenow) were purchased from Boehringer 
Mannheim. The T4 DNA ligase and T4 polynucleotide kinase 




were obtained from Sigma Chemical 
dTTP, 3,000 uci/mmle (lCi = 37 
purchased from Amersham. 
BACTERIAL CELL LINES 
Co. The 
GBq) I was 
E. coli HBlOl cells containing wild-type or mutant 
beta-lactamase genes in pBR 322 were grown in LB media. 
For growth of plasmid containing the tac promoter, E. coli ---
q 
strain Dl210 was used as a host. E. coli Dl210 is a lac I 
derivative of HBlOl. 
DNA 
Plasmid DNA was prepared according to standard 
procedures (20). Numbering of the pBR322 is the one 
commonly used (20). 
DNA fragments were purified from 1.2% low-melting-point 
agarose gels according to standard methods (20). 
Oligonucleotides were synthesized by using the 
phosphoramidite chemistry (21) on the Applied Biosystems 
(Foster City,CA) DNA synthesizer, model 380A and purified 
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by preparative polyacrylamide gel electrophoresis. 
REACTIONS FOR CASSETTE MUTAGENESIS 
Individual oligonucleotide strands were phosphorylated 
using standard procedures (20). 
Oligonucleotide strands were annealed by mixing 0.5 
0 
pmole /µl of each strand and incubating at 95 c for 5 min 
in 50 mM Tris-HCl buffer, pH 8, containing 10 mM MgCl , 
2 
followed by gradual cooling to room temperature over a 45 
minute period. 
For ligations, approximately 0.05 pmole of each 
restriction fragment and 0.5 pmole of the annealed 
synthetic fragment, were mixed in 50 mM Tris-HCl buffer, 




and 10 units of T4 DNA ligase and incubated 
at 15 C for 16 hours. The reaction mixture was used 
directly to transform competent ~ coli HBlOl cells. Cell 
transformations were done by standard methods (22). 
CASSETTE MUTAGENESIS 
To introduce the double mutations at site 71 and site 
72 of RTEM-1 beta-lactamase, the following mixture of 
oligonucleotides, 
5 1 - CC GAG GAA CGT TTT CCA ATG 
C CTT GCA AAA GGT TAC [
AT J ATG AGC CCT ACT AAA 
TAC TCG ~~ TGA TTT 
was ligated into the plasmid as shown in Figure 1. 
GT 
CA-5 1 
After ligation and transformation as described above 
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the cells were spread on L-agar plates containing 25 µg/ml 
tetracycline. 
DNA SEQUENCING 
The plasmids were digested with Ava I and the resulting 
2,962 base-pair fragments were isolated as described above. 
The fragment was labeled at nucleotide T-3973 using [alpha-
32 
P] dTT, and the Klenow fragment of DNA polymerase I. The 
labeled fragment was sequenced by the method of Maxam and 
Gilbert (23). 
AMINO ACID DERIVATIVES 
The benzyl ester of D-alanine was prepared 
method described by Guttmann and Boissonnas (24). 
by the 
Alpha-
Boc-E-benzyloxycarbonyl-L-lysine was purchased from Sigma. 
Boc-D-alanine was prepared by the procedure as described 
( 25) . The N-hydroxy-succinimide ester of alpha-Boe-€ -
benzyloxycarbonyl was prepared as described (26). 
SYNTHESIS OF ALPHA-BOC-E{Z)-L-LYS-D-ALA-D-ALA(BZL) 
This compound was synthesized by the method of Nieto 
and Perkins as shown in Figure 1 (27). The benzyl ester 
(free base) of D-alanine was coupled to the Boc-D-alanine 
by means of dicyclohexylcarbodiimide in dichloromethane at 
0 
o c overnight. Dicyclohexylurea was removed by filtration 
and the protected di peptide was purified by 
recrystallization from ethylacetate-n-hexane. The yield was 
about 86% of the theoretical. The tert-butyloxycarbonyl 
group was removed by treatment with anhydrous 
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0 
trifluoroacetic acid at o C for 15 minutes. The 
trifluoroacetic acid was evaporated under vacuum, and the 
excess was removed by repeated dissolution in 80% acetic 
0 
acid and concentration in vacuo at 40 c. Finally, the 
trifluoroacetate salt was dried in vacuo over KOH and P o . 
2 5 
Coupling of the dipeptide benzyl ester trifluoroacetate 
with the N-hydroxysuccinimide ester of alpha-Boe- -
benzyloxycarbonyl-L-lys was carried out as described by 
Anderson et al. (26) • The protected tripeptide was 
recrystallized from ethylacetate-n-hexane. The yield was 
about 82% of the theoretical value. The melting point of 
0 0 
the protected tripeptide is 127 - 128 c, which is very 
0 0 
close to the published one, 126 - 127 c. 
SYNTHESIS OF DI-ACETYL-L-LYS-D-ALA-D-ALA 
The benzyl group was first removed by hydrogenation in 
80% acetic acid, with 10% Pd/C as catalyst, to give the N-
acetylated peptide. The tert- butyloxycarbonyl group was 
then removed by the method as described above. The free 
peptide L-lys-D-ala-D-ala (1 mmole) was dissolved in 
0 
dioxane-water (1:1, v/v) (10 ml), cooled at O c (ice bath), 
and triethylamine (5 mmole) was added followed by acetic 
anhydride (2.5 mmole). The mixture was kept on ice for 2 
hours, boiled for 3 minutes to destroy any excess of acetic 
anhydride, evaporated to dryness, redissolved in water and 
evaporated again. The yield of crude product was about 60% 
of the theoretical value. The crude product was 
redissolved 
+ 
Dowex 50 (H 
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in water and further purified on a column of 
form) and recrystallized from ethanol-hexane. 
0 0 
The melting point is 200 -201 c. 
3 
SYNTHESIS OF l-HJ-DIACETYL-L-LYS-D-ALA-D-ALA 
This substrate, which was radioactively labeled in the 
acetyl group, was prepared as described by Perkins and 
3 
Nieto (28). [1- HJ - acetic anhydride (50 mci; 26.6 
mci/µmole) was condensed at the bottom of the ampoule 
provided by the supplier (The Radiochemical Centre, 
0 
Amersham, Bucks., U.K.) by cooling it to -80 c and warming 
slightly the rest of the ampoule. The top of the ampoule 
was broken and L-lysyl-D-alanyl-D-alanine (3 µmole) and 
triethylamine (1 µl) in water-dioxane (1:1,v/v) (4 µl) were 
added quickly. The frozen solution was melted, mixed 
thoroughly and kept in an ice bath for 1 hour. Then 1 µl 
of acetic anhydride (non-radioactive) was added and the 
reaction was allowed to proceed for one more hour in the 
ice bath, The reaction mixture was heated for 1 minute at 
0 
100 c, concentrated to dryness, redissolved in water and 
finally purified by paper electrophoresis in pyridine-
acetate buffer (acetic acid : pyridine : water = 1 : 25 : 
475), pH 6.5 (60 v/cm, 1 hour). The purified product gave 
a single radioactive spot after high-voltage 
electrophoresis under conditions that would detect > 0.1% 
radioactive impurity. 
ASSAY FOR D,D = CARBOXYPEPTIDASE ACTIVITY 
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Assays of the mutant beta-lactamases and RTEM-1 beta-
o 
lactamase were performed at 37 C in mixtures containing 0.1 
3 
M Tris-HCl (pH 7.5), 160 nmole of [HJ diacetyl-L-Lys-D-
Ala-D-Ala ( specific activity, 67.lmCi/mmole) and 20 ug of 
enzyme in a total volume of 60 µl. The extent of 
conversion of diacetyl-L-Lys-D-Ala-D-Ala to diacetyl-L-Lys-
D-Ala was determined by seperating the compounds by high-
voltage paper electrophoresis in water / acetic acid / 
pyridine, 1,000: 10: 1 (v/v), buffer pH 3.5, locating 
each by cutting Whatman 3MM paper in pieces and assaying 
the radioactivity (relative mobilities: diacetyl-L-Lys-D-
Ala-D-Ala, 20cm; diacetyl-L-Lys-D-Ala, 29cm). 
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RESULTS 
The diad Thr71Phe72 of RTEM-1 beta-lactamase has been 
simultaneously changed into Thr71Thr72, Leu71Thr72, 
Ile71Thr72 and Pro71Thr72 by cassette mutagenesis. The 
scheme for cassette mutagenesis shown in Figure l is 
adapted from Schultz and Richards (19). A mixture of 
synthetic oligonucleotides was used in directing 
mutagenesis. After three-piece ligation and 
transformation, about 120 colonies were obtained on the 
tetracyline plate. These colonies were separated into four 
groups according to their resistant phenotypes to 
benzylpenicillin and ampicillin. Several colonies from 
each group were selected and their DNA sequences were 
confirmed by the method of Maxam and Gilbert (23). The 
mutagenized genes were subcloned into pJN plasmid for 
expression. The pJN plasmid was constructed by Jim Neitzl 
and contains a tac promoter as well as a gene for 
kanamycine resistance. This plasmid can be used in 
production of a beta-lactamase mutant that shows no beta-
lactamase activity. 
Cells producing either T71L, F72T or T71P, F72T mutant 
of beta-lactamase display no resistant phenotype to 
ampicillin and cephalothin. These two mutant proteins have 




F72T mutants of beta-lactamases have been 
and partially characterized. The kcat and Km 
values of these mutant beta-lactamases are shown in Table 
1. The T71T, F72T mutant of beta-lactamase shows 52.7% 
kcat/Km value of the wild-type beta-lactamase. The T71I, 
F72T mutant of beta-lactamase shows only 0.11% 
kcat/Km value of the wild-type beta-lactamase. Table 2 
shows that the thermal stability of the T71T, F72T mutant 
of beta-lactamase is worse than that of the wild-type beta-
lactamase; the thermal stability of T71I, F72T mutant of 




When suitable restriction sites are available in the 
original vector plasmid or suitable new restriction sites 
have been created, cassette mutagenesis becomes a much 
easier way to generate specific mutations at desired sites 
than the oligonucleotide-directed mutagenesis. It also 
becomes possible to generate many mutations at the same 
time by cassette mutagenesis; for example, one amino acid 
can be replaced by the 19 possible substitutions in one 
experiment (9). 
To continue studying the roles of residue 71 and 72 in 
the catalytic activity, thermal stability and substrate 
specificty of RTEM-1 beta-lactamase, and to study the 
possibility of creating a substantial D,D-carboxypeptidase 
activity within the structural background of a beta-
lactamase, I have changed the diad Thr71Phe72 of RTEM-1 
beta-lactamase into Thr71Thr72, Ile71Thr72, Pro71Thr72 and 
Leu71Thr72 by cassette mutagenesis. 
Among those mutant proteins, the T71T, F72T and T71I, 
F72T mutants of beta-lactamase were purified and partially 
characterized. The thermal stability of T71T, F72T mutant 
of beta-lactamase is worse than that of the wild-type beta-
lactamase and the thermal stability of T71I, F72T mutant 
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beta-lactamase is also worse than that of the T71I mutant 
of beta-lactamase. These results indicate that the Phe72 
residue of RTEM-1 beta-lactamase may play an important role 
in the stability of this enzyme. 
The T71T, F72T mutant beta-lactamase shows 52.7% of the 
kcat/Km value of the wild-type beta-lactamase, indicating 
that residue 72 may not be involved directly in either 
binding or catalysis. The T71I mutant of beta-lactamase 
shows 7.25% of the kcat/Km value of wild-type beta-
lactamase; however, the T71I, F72T mutant of beta-lactamase 
shows only 0.11% of the kcat/Km value of wild-type beta-
lactamase. These results suggest that residues 71 and 72, 
though themselves not being involved directly in catalysis, 
may play a very important role in keeping the active site 
Ser70 and the conserved residue Lys73 in the correct 
orientation for efficiently catalyzing the hydrolysis of 
the beta-lactam antibiotics. In other words, the 
orientation between the active site Ser and the conserved 
Lys residue in mutant beta-lactamases, wild-type beta-
lactamase and D,D-carboxypeptidases may be different from 
one another because each of them contains different diads 
between the two conserved residues, so that different 
mutant beta-lactamases and D,D-carboxypeptidases might have 
different catalytic activities ~gainst beta-lactam 
antibiotics. This may be the reason that the D,D-
carboxypeptidases containing the conserved triad, Ser-Xaa-
64 
Thr-Lys, can't catalyze the hydrolysis of the beta-lactam 
antibiotics very efficiently and that the mutant beta-
lactamase of B. aureus PCl containing the sequence, Ser-
Ile-Ser-Lys, shows no beta-lactamase activity (10), but the 
mutant RTEM-1 beta-lactamase containing the sequence, Ser-
Ile-Phe-Lys, 
activity. 
still shows significant beta-lactamase 
It would be interesting to know whether a 
mutant D,D-carboxypeptidase containing the sequence, Ser-
Thr-Phe-Lys, can catalyze the hydrolysis of beta-lactam 
antibiotics more efficiently than the wild-type D,D-
carboxypeptidase and whether a mutant beta-lactamase of B. 
aureus PCl containing the sequence, Ser-Ile-Phe-Lys, can 
regain some beta-lactamase activity. Positive answers for 
the questions posed above may further support the view that 
the two residues between the active site Ser and the 
conserved Lys residues do play an important role in keeping 
the two conserved residues Ser and Lys in the correct 
orientation for efficiently catalyzing the hydrolysis of 
beta-lactam antibiotics. 
Another more interesting question is whether the 
orientation between Ser71 and Lys73 and the penicillin-
binding site in these mutant beta-lactamases have been 
changed in such a way that these mutants can now catalyze 
reactions characteristic of D,D-carboxypeptidases. This 
possibility was tested by the use of the model substrate 
3 
( H]-diacetyl-L-Lys-D-Ala-D-Ala. Neither of the mutant 
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proteins described in Chapter 1 and this chapter show 
detectable D,D-carboxypeptidase activity. It is possible 
that either the amino acid residues used in binding or 
catalysis by D,D-carboxypeptidases are different from those 
used by beta-lactamases or that, in these two groups of 
enzymes, the spatial arrangement of the same amino acid 
residues involved in binding or catalysis is different. 
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COMPARISON OF CATALYTIC PARAMETERS OF 
WILD-TYPE AND MUTANT BETA-LACTAMASES 
AGAINST AMPICILLIN 
Krn(µM) -1 kcat(sec ) -1 -1 kcat/Krn(µM sec ) 
50 2,000 40 
50 145 2.9 
80 3.6 0.045 
16 338 21. l 
kcat/Krn of mutant : kcat/Krn of wild type 
T71I, F72 T71I, F72T T71, F72T 
0.073 0.0011 0.53 
TABLE II 
THERMAL STABILITY OF ACTIVE BETA-LACTAMASES 
t1 
Temperature 2 
* T71, F72 T71, F72T T71I, F72 
40°C ------ > 30 ~ min1 ) 30 min 
0 
50 c ) 30 min 15 min 5 min 
55°c 1-3 min 8 min < 1 min 
6v°C 1-2 min < 1 min ------
*From Jim Neitzel's data for wild-type beta-lactamase. 
T71I, F72T 
> 30 min 
7 min 






SYNTHESIS OF DIACETYL-L-LYS-D-ALA-D-ALA 
Abbreviations : Boe, t-butyloxycarbonyl; Bzl, benzyl; 
DCC, dicyclohexylcarbodiimide; Nhs, N-hydroxysuccinimide; 
z, benzyloxycarbonyl. 
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D-Ala-OH D- Ala-OH 
l Boc-N3/pH 9.8 I HO-Bzl/polyphosphoric ~ acid 
Boc-D-Ala-OH -r 
( m.p., 8J-84°c) 
D-Ala-0-Bzl 
Boc-D-Ala-A-Ala (Bzl) (m.p., ?l-72°C) 
11. CF3 COOH, 8~ CHJCOOH 2. c.t-Boc- f -Z-Lys-Nhs/Et3N (m.p. 60-6J°C) 
Cl-Boe- E'-Z-L-Lys-D-Ala (Bzl) (m.p. 127-128°C) 
1. CF3COOH, 8~ CHJCOOH 
2. H2 /Pd 
). Ac20/Et3N 




CONSTRUCTION OF A HYBRID PROTEIN 
TO STUDY THE STRUCTURE-FUNCTION 




The amino acid sequences around the active site serine 
of beta-lactamases show significant homology to those 
around the penicillin binding sites of the D,D-
carboxypeptidases, leading to the proposal that these beta-
lactamases may have evolved from D,D-carboxypeptidases (1, 
2). Both groups of enzymes are acylated by beta-lactam 
antibiotics (3) and are able to catalyze the hydrolysis of 
certain acyclic depsipeptides (4). However, only D,D-
carboxypeptidases can catalyze the hydrolysis of the 
acyclic peptides, involving the terminal D-Ala-D-Ala moiety 
of the peptidoglycan cross-link (1). It has been 
demonstrated that there is a significant similarity in the 
spatial arrangement of the elements of secondary structure 
in these two groups of enzymes (5, 6). 
In Chapter II, to study the possibility of creating a 
substantial D,D-carboxypeptidase activity within the 
background of beta-lactamase structure, I have generated 
several mutant beta-lactamases with D,D-carboxypeptidase-
like sequences in the immediate vicinity of the active site 
serine 70. None of these mutants shows detectable D,D-
carboxypeptidase activity. Possibly, the amino acid 
residues used 
carboxypeptidases 
in binding or catalysis by 




lactamases. It is also possible that the spatial 
arrangement of the same amino acid residues involved in 
binding or catalysis in D,D-carboxypeptidases is different 
from the spatial arrangement of those corresponding amino 
acid residues in beta-lactamases. In other words, to be 
able to generate a mutant beta-lactamase that can catalyze 
appreciable D,D-carboxypeptidase activity, we may have to 
replace more than two amino acid residues around the active 
site serine of beta-lactamases with those corresponding 
amino acid residues of D,D-carboxypeptidases. 
In both enzymes, the active site serine is near the 
NH -terminus. The spatial location of the beta-lactam 
2 
binding site in the D,D-carboxypeptidase is shown in Figure 
2a (7). It is flanked on one side by the beginning of the 
alpha-A helix, at the rear by the beta-A strand of the 
beta-sheet and at the bottom by the alpha G helix. Amino 
acid side chains potentially able to contact a beta-lactam 
are in a 20-residue coil of polypeptide in the NH -terminal 
2 
portion of the molecule as shown in Figure 2b (7). Although 
the spatial location of the beta-lactam binding site in the 
beta-lactamase has not been worked out, one comparable to 
that of the D,D-carboxypeptidase might be expected. 
Among the D,D-carboxypeptidases whose amino acid 
sequences are known, PBP5 of E. coli is the one that 
contains the most homologous amino acid sequence around the 
active site serine when compared with the class A beta-
78 
lactamases (8). PBP5 can also catalyze a weak beta-
lactamase activity, indicating that it may be more closely 
related to beta-lactamases than other D,D-carboxypeptidases 
(9). Combining the reasons described above with the 
consideration of suitable restriction endonuclease sites 
existing in the gene of RTEM-1 beta-lactamase, I decided to 
construct a hybrid protein with the replacement of a 
polypeptide of 29 amino acid residues of RTEM-1 beta-
lactamase by the corresponding polypeptide of PBP5 of E. 
coli, which contains the amino acid residues 
able to contact the binding substrate (7); 
consists of 30 amino acids. 
potentially 
this peptide 
The gene encoding the hybrid protein was constructed by 
the use of cassette mutagenesis as shown in Figure 3. For 
checking the in vivo stability of the hybrid protein, the 
mutagenized gene was cloned into pBR322. For production of 
hybrid protein, the mutagenized gene was cloned into pJN 
plasmid containing a tac promoter. Cells producing the 
hybrid protein do not display a resistance phenotype 
against any beta-lactam antibiotics. The result obtained 
by the use of western blot indicates that the in vivo 
stability of the hybrid protein is reasonably good. 
Interestingly, given the objective, the purified hybrid 
protein shows 1.8% D,D-carboxypeptidase activity of the 
wild-type PBP5 of E. coli. This result further supports 
the hypothesis that beta-lactamases are evolutionarily 
79 
related to D,D-carboxypeptidases(l). Moreover, this hybrid 
protein shows no transpeptidase activity, suggesting that 
the alpha-G helix in D,D-carboxypeptidase may play an 
important role in the transpeptidation reactions. 
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MATERIALS AND METHODS 
ENZYMES AND CHEMICALS 
Restriction enzymes and the large fragment of DNA 
polymerase 
Mannheim. 
I (Klenow) were purchased from Boehringer 
The T4 DNA ligase and T4 polynucleotide kinase 
were obtained from Bethesda Research Laboratories. All 
antibiotics were obtained from Sigma Chemical Co. The 
32 
[alpha- P]dCTP, 3,000 µCi/mmole (1 Ci =37 GBq) was 
purchased from Amersham. 
CELLS 
~ coli HBlOl cells containing wild-type or hybrid gene 
in pBR322 were grown in LB media. For growth of plasmid 
containing the tac promoter, ~ coli strain Dl210 was used 
q 
as a host. E. coli Dl210 is a lac I derivative of HBlOl. 
DNA 
Plasmid DNA was prepared according to standard 
procedures (10). 
commonly used (10). 
Numbering of the pBR322 is the one 
DNA fragments were purified from 1.2% low melting point 
agarose gels according to standard methods (10). 
Oligonucleotides were synthesized by the use of 
phosphoramidite chemistry (11) on the Applied Biosystems 
(Foster city, CA.) DNA synthesizer, model 380A and purified 
by preparative polyacrylamide gel electrophoresis. 
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REACTIONS 
Individual oligonucleotide strands were phosphorylated 
using standard procedures (10). 
Oligonucleotide strands were annealed by mixing 0.5 
0 
pmole/µl of each strand and incubating at 90 C for 5 min in 
50 mM Tris-HCl buffer, pH 8, containing 10 rnM MgCl , 
2 
followed by gradual cooling to room temperature over a 45 
minute period. 
For ligations, approximately 0.05 pmole of each 
restriction fragment and 0.5 pmole of the annealed 
synthetic fragment were mixed in 50 rnM Tris-HCl buffer, 
pHB, containing 10 rnM MgCl , 0.5 mMATP, 5 rnM dithiothreitol 
2 0 
and 10 units of T4 DNA ligase and incubated at 15 c for 16 
hours. The reaction mixture was used directly to transform 
competent E. coli HBlOl cells. Cell transformations were 
done by standand methods (12). 
CONSTRUCTION OF THE HYBRID GENE 
The EcoRI-PstI fragment containing part of the beta-
lactamase gene was first cloned into Ml3mp8. The newly 
constructed vector DNA was designated as Ml3mp8-DC9. The 
annealed four-piece synthetic oligonucleotide, which 
encodes the exact amino acid sequence around the active 
site serine of PBP-5 of E. coli, was then cloned into 
Ml3mp8-DC9 as shown in Figure 2. 
After ligation and transformation as described above, 
the plaques were formed on YT-agar plates. The plaques 
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containing the mutant gene were identified by the 
restriction maps of the RFs digested with Ava I and Bgl I. 
DNA SEQUENCING 
The plasmids were digested with Xho II and Pst I, and 
the resulting 314 base pair fragment was isolated. This 
fragment was labeled at nucleotide G-3923 using [alpha-
32 
P]dCTP and the Klenow fragment of DNA polymerase I. The 
labeled fragment was sequenced by the method of Maxam and 
Gilbert (13). 
PROTEIN GELS AND IMMUNO BLOT 
Whole cell extracts were prepared from E. coli 
harboring plasmids encoding either mutant or wild-type 
beta-lactamase. The 
-1 
(O.D. at 600 nm ), 
cells were grown to late 




measured. The cells were pelleted by centrifugation and 
resuspended in loading buffer [10% (vol/vol) glycerol / 5% 
(vol/vol) 2-mercaptoethanol /3% (wt/vol) sodium dodecyl 
sulfate/ 62.5 mM Tris-HCl, pH 6.8 /l.O mM EDTA] and lysed 
0 
after being incubated 10 minutes at 95 c. Cells from 
cultures with densities of 1 O.D. were resuspended in 100 
µl of loading buffer; cells from cultures with slightly 
higher or lower densities were resuspended in a 
proportionally greater or lesser volume of loading buffer. 
Aliquots of 20 µl of these mixtures were loaded directly 
onto a 15 cm 12% polyacrylamide gel with a 2 cm 4% stacking 
gel and electrophoresed at 5 mA for approximately 12 hours. 
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The protein was transferred from the polyacrylamide gel 
to nitrocellulose by electrophoresis (electrophoretic blot 
or western blot) according to the Bio-Rad procedure (14) 
the polyacrylamide gel was washed for 30 minutes in 25 mM 
Tris base / 192 mM glycine (pH 8.3) / 20% (vol/vol) 
methanol; the gel was then sandwiched between blotting 
paper and pure nitrocellulose (Schleicher and Scheull) and 
electrophoresed in a Bio-Rad Trans-Blot cell at 50 V for 5 
hours. 
The nitrocellulose membrane was first treated with a 
solution of 1% (wt/vol) BSA and 0.1% (vol/vol) normal goat 
serum for 1.5 hours at room temperature. The membrane was 
stained according to the procedure from the Vectastain ABC 
kit (15) using antibodies raised against beta-lactamase in 
rabbits. The initial injection used to raise the 
antibodies contained denatured beta-lactamase purified by 
SDS/polyacrylamide gel electrophoresis (16); booster shots 
contained protein purified as described elsewhere (16). Two 
weeks after the booster shot, the rabbit was bled and the 
serum was collected and used without further purification. 
For binding of the primary antibody, a 1 : 1,000 dilution 
of rabbit antiserum in TPBS was incubated with the 
nitrocellulose membrane for 1 hour at room temperature. 
PRODUCTION and PURIFICATION OF THE HYBRID PROTEIN 
The mutagenized gene was cloned into pJN plasmid for 
expression. The induction condition was the same as that 
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described in Chapter 2. The purification procedure was 
basically the same as that described in Chapter 1 except 
that ampicillin was added to a concentration of 40 µg/ml in 
all the buffers used in the procedure. Before purifying 
the hybrid protein on the Ultragel column, I had previously 
purified the hybrid protein twice on a DE-52 column. Those 
fractions that showed single bands on 12% sos-
polyacrylamide gel were pooled and used for further tests. 
ASSAY FOR D,D-CARBOXYPEPTIDASE & TRANSPEPTIDASE ACTIVITY 
Assays of the mutant beta-lactamases and RTEM-1 beta-
o 
lactamase were performed at 37 c in mixtures containing 0.1 
3 
M Tris-HCl (pH 7.5), 160 nmole of [HJ diacetly-L-Lys-D-
Ala-D-Ala (specific activity, 67.1 µCi/umole) and 20ug of 
enzyme in a total volume of 60µ1. The starting material, 
diacetyl-L-Lys-D-Ala-D-Ala, and the reaction products were 
separated by high-voltage electrophoresis in water / acetic 
acid/ pyridine, 1,000 10 : 1 (v/v) buffer pH 3.5. The 
Whatman 3 MM paper was then cut into pieces (0.25 
inch/piece) . Each piece of the 3 MM paper was soaked in 1 
ml of ddH o at room temperature with constant shaking; 
2 
after 30 minutes, an aliquot of 100 from each vial was 
transferred into a scintillation vial containing 10 ml of 
scintillation fluid. The starting material and the 
reaction products were located by assaying the 
radioactivity of each vial and comparing their relative 
mobilities (18). The plot was shown in Figure VIII 
85 
(relative mobilities : diacetyl-L-Lys-D-Ala-D-Ala, 20 cm; 
diacetyl-L-Lys-D-Ala, 29 cm). The extent of conversion of 
diacetyl-L-Lys-D-Ala-D-Ala was derived from the ratio of 
the radioactivity of diacetyl-L-Lys-D-Ala to diacetyl-L-
Lys-D-Ala-D-Ala. 
The pH profile of the D,D-carboxypeptidase activity of 
the hybrid protein was obtained by the use of Tris-HCl or 
KOAc buffer at different pH values. Carbonate and 
phosphate buffers at different pH values have also been 
used to test their effects on the D,D-carboxypeptidase 
activity of the hybrid protein. 
For assaying the transpeptidase acitvity of the hybrid 
protein, the same conditions described above were used 




Table 1 shows the amino acid sequence of RTEM-1 beta-
lactamase, which has been replaced, and the amino acid 
sequence of PBP5 of E. coli, which has been substituted in 
its place into RTEM-1 beta-lactamase. The gene encoding 
the hybrid protein was constructed by cassette mutagenesis 
as shown in Figure 3. After three-piece ligation and 
transformation, the plaques containing the hybrid gene were 
identified by comparing the restriction maps of the RF DNAs 
digested with Ava I and Bgl I. After the digestion, the 
wild-type RF shows three bands: however, the mutant RF 
shows only two bands. The results are shown in Figure 4. 
The DNA sequence was further confirmed by the method of 
Maxam and Gilbert (17). The mutagenized gene was cloned 
back into pBR322 for checking its resistance to beta-lactam 
antibiotics and into pJN for expression. Cells containing 
the mutagenized gene do not display a resistant phenotype 
against any beta-lactam antibiotics. The in vivo stability 
of the hybrid protein was checked by western blot. The 
results are shown in Figure 5. The hybrid protein produced 
in 01210 cells was purified twice on a DE-52 column and 
then once on an Ultagel column . This hybrid protein elutes 
off the DE-52 column more slowly than the wild-type RTEM-1 
beta-lactamases as shown in Figure 6. To stabilize the 
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hybrid protein, ampicillin was added to 40 ug/ml in all the 
buffer used in the purification procedure. The hybrid 
protein purified under this modified condition shows about 
30 times increase in its beta-lactamase activity and about 
15 times increase in its D,D-carboxypeptidase activity over 
the protein purified in the absence of ampicillin. The 
purity of the isolated hybrid protein was checked on 12% 
SDS-polyacrylamide gel. The results are as shown in Figure 
7. 
The purified hybrid protein has been partially 
characterized. The specific activity of this hybrid 
-1 -1 
protein is 1.1 sec on ampicillin and 1.32 sec on 
benzylpenicillin. The D,D-carboxypeptidase activity of 
-3 -1 
this hybrid protein is about 3.5 x 10 min as shown in 
Figure 9 and Table 2. Figure 10 shows a comparison between 
the pH profile of the D,D-carboxypeptidase activity of the 
hybrid protein and that of PBP-5 of E. coli (9). This 
figure also shows the differences in the effects of 
phosphate and carbonate buffers on the D,D-carboxypeptidase 
activity of these two proteins. 
The transpeptidase activity of the purified hybrid 
protein has also been tested. The substrates used were 
3 
[ H]-diacetyl-L-Lys-D-Ala-D-Ala and glycine. When 100 mM 
glycine was added to the reaction mixture, the hybrid 
protein showed only 80% of its D,D-carboxypeptidase 
activity obtained under the condition without glycine. 
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After the reaction mixture containing lOOmM glycine had 
0 3 
been incubated at 37 C for 24 hrs, [ H]-diacetyl-L-Lys-D-
Ala was the only reaction product detected. In other 
words, this hybrid protein shows no detectable 
transpeptidase activity. However, under the same reaction 
conditions for the wild-type PBP-5 of E. coli, in 30 
minutes, 80% of the reaction product is 
diacetyl-L-Lys-D-Ala-Gly, and only 20% of the reaction 
product is diacetyl-L-Lys-D-Ala (9). 
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DISCUSSION 
Since the introduction of site-directed mutagenesis as 
an approach for studying structure-function relationships 
in proteins in 1982 (19, 20), many such studies have been 
reported (21-32). This work strengthens the view that the 
site-directed mutagenesis technique, when combined with 
classical enzymology and structural analysis, can become a 
very powerful tool to gain insights into the molecular 
basis of enzymatic catalysis. Recently, construction of 
hybrid proteins has been demonstrated to be a successful 
approach for creating new proteins with desired functional 
properties (33, 34); it has also been used as another 
approach for studying the structure-function relationships 
between evolutionarily and structurally related proteins. 
Using cassette mutagenesis, when suitable endonuclease 
restriction sites exist in a cloned gene, one can easily 
replace a segment of the cloned gene with another designed 
gene fragment. Hybrid protein can thus be obtained by the 
expression of the hybrid gene. 
The mutant 434 repressor with the replacement of its 
putative recognition alpha-helix with the putative 
recognition alpha-helix of 434 cro protein shows a change 
in its DNA-binding specificity to that of 434 cro protein 
(33). The construction of a hybrid protein of Lex A, an ~ 
90 
coli repressor protein, and GAL4, a Saccharomyces 
cerevisiae transcriptional activator, successfully 
demonstrated that the DNA binding function of GAL4 can be 
replaced with that of a prokaryotic repressor without loss 
of the transcriptional activation function (34). Moreover, 
chimeric antibodies, which represent unique combinations of 
heavy and light chains, have been created by means of 
recombinant DNA technology (35, 36). Here, we present the 
first example of creating a new enzyme with desired 
catalytic function by the construction of a hybrid protein. 
This hybrid protein was constructed by the replacement 
of a polypeptide chain containing 29 amino acid residues 
[from residue 47 to 75, in the number system of Ambler 
(37)] of RTEM-1 beta-lactamase with the corresponding 
sequence containing 30 amino acid residues of PBP-5 of E. 
coli. When comparing the amino acid sequence of this 
hybrid protein with that of RTEM-1 beta-lactamase, we find 
that there is an insertion between residue 56 and 57 in the 
hybrid protein and that there are 18 substitutions of amino 
acid residues between these two proteins. 
Although the in vivo stability of this hybrid protein is 
reasonably good, the thermal stability of the purified 
hybrid protein is poor. When assaying the catalytic 
activity of the hybrid protein purified in the absence of 
ampicillin, I found that there was a lag of about 15 
minutes. A likely explanation for this finding is that the 
91 
hybrid protein undergoes a conformational change after it 
binds to the beta-lactam antibiotics. Interestingly, 
although the thermal stability of the hybrid protein is 
poor, it can catalyze the hydrolysis of beta-lactam 
antibiotics with a constant rate for a period of 30 minutes 
0 
when assayed at 55 c. This result suggests that the 
conformation of the hybrid protein can be stabilized by its 
binding to beta-lactam antibiotics. This finding led me to 
add excess ampicillin in all the buffers used in the 
purification procedure as described in the Methods section. 
Indeed, the hybrid protein purified by this modified 
condition shows about 30 times increase in its beta-
lactamase activity and about 15 times increase in its D,D-
carboxypeptidase activity over the protein purified in the 
absence of ampicillin. All the data shown in this chapter, 
unless specifically indicated, were obtained by the use of 
the hybrid protein purified by the improved purification 
procedure. 






against benzylpenicillin; interestingly, this 
also shows 
-3 






The wild-type RTEM-1 beta-
-1 
has a kcat value of 1,700 sec against 
benzylpenicillin and shows no detectable D,D-
carboxypeptidase activity (38). The wild-type PBP5 of E. 





carboxypeptidase of 0.19 min 
shows a specific D,D-
( 9} • In other words, this 
hybrid protein shows about 1.8% of the D,D-carboxypeptidase 
-3 
activity of the wild-type PBP5 of ~ coli and about 10 of 
the specific activity of the wild-type beta-lactamase 
against benzylpenicillin. These results further support 
Tipper and Strominger's hypothesis that beta-lactamase may 
be evolutionarily related to D,D-carboxypeptidases (1). 
The pH profile of the D,D-carboxypeptidase activity of 
the hybrid protein is different from that of the wild-type 
PBP5 as shown in Figure 10. The optimal pH for the D,D-
carboxypeptidase activity of the hybrid protein is about 
8.5; at pH 9, the hybrid protein shows only 40% of its 
optimal D,D-carboxypeptidase activity. However, the 
optimal pH for the wild-type PBP5 in Tris-HCl buff er is 
about 10 as shown in Figure 10. Moreover, both phosphate 
and carbonate buff er have been shown to be inhibitory for 
the activity of the wild-type PBP5 of E. coli ( 9} ' but 
phosphate buff er shows no such effect on the D,D-
carboxypeptidase activity of the hybrid protein, and 
carbonate buff er shows less effect on the D,D-
carboxypeptidase activity of the hybrid protein than on the 
activity of wild-type PBP5 of ~ coli. 
Another interesting finding is that the wild-type PBP5 
(mol. wt. 42,000} of ~ coli shows transpeptidase activity 
(9), but the hybrid protein (mol. wt. 28,500} does not. It 
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has been postulated that the portion of the COCH-terminal 
domain of helices E, F, G and H in R-61 D,D-
carboxypeptidase could be involved in peptidoglycan binding 
during cell well biosynthesis (7). The major structural 
difference between the R61 D,D-carboxypeptidase and the 
class A beta-lactamase of B. licheniformis 749/C and B. 
cereus 569 is that both class A beta-lactamases lack the 
correponding alpha-G helix in their chystallographic 
structures. It is likely that there is no such alpha-G 
helix in the structure of hybrid protein either; this may 
be the reason that the hybrid protein shows no 
transpeptidase activity. Further understanding in the 
structure-function relationships between beta-lactamases 
and D,D-carboxypeptidases will require higher resolution of 
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TABLE I 
* A. - D L N S G K i L e S - f r p e e R f p m m S t f K v 1 1 c G -
* B. - D L N S G K v L a e e q n a d v R rd p a S e t Km m t s G -
A. The amino acid sequence of RTEM-1 beta-lactamase 
which has been replaced. 
B. The amino acid sequence of PBP-5 of E. coli which 
has been substituted into RTEM-1 beta-lactamase. 





SECONDARY-STRUCTURE ELEMENTS IN B. LICHENIFORMIS 749/C, 
STREPTOMYCES R61 AND BE~A-LACTAMASE I. 
A Secondary-structure elements in ~ licheniformis 749/C 
beta-lactamase (left) and in Streptomyces R61 D,D-
carboxypeptidase (right). This is taken from Ref.5 . 
B Secondary-structure elements of beta-lactamase I 
0 
derived from analysis at 2.5 A resolution. This is 






A Main chain folding schematic of Streptomyces R61 D,D-
carboxypeptidase. 
B A yz projection of alpha-carbon atoms 25-42 (dots) 
showing folding of active site polypeptide around the 
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RESTRICTION MAPS OF RFs DIGESTED WITH Ava I AND Bgl I 
After the digestion of RFs with Ava I and Bgl I,the RF 
of the wild type will be cut into three pieces, but the RF 
of 
The 
the putative mutant will be cut into only two 
plaque that gave the result shown in b lane 







WESTERN BLOT OF THE MUTANT BETA-LACTAMASES 
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THE ELUTION PROFILE OF THE HYBRID PROTEIN ON DE-52 COLUMN 
The arrows indicate the fractions pooled for further 
purification. When the wild-type beta-lactamase was 
purified on the same column under the same condition, the 
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12% SDS/POLYACRYLAMIDE GEL ELECTROPHORESIS 
OF THE HYBRID PROTEIN 
This hybrid protein was purified once on a DE-52 column 
(A), twice on a DE-52 column (B) and finally on an Ultragel 
column (C). In picture c, lane a shows the purity of the 
wild-type beta-lactamase; lane b shows the purity of the 
hybrid protein; lane c shows the purity of the partially 
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SPECTRUM OF THE RESULT OF THE HYDROLYSIS 
3 
OF [ H]-DIACETYL-L-LYS-D-ALA-D-ALA 
BY THE HYBRID PROTEIN 
[ H]-diacetyl-L-Lys-D-Ala-D-Ala (specific 
67.1 mci/nunole) was used as the substrate. 
activity, 
The D,D-
carboxypeptidase activity of the hybrid protein was assayed 
under the condition as described in the Methods section. 
0 
After the reaction mixture had been incubated at 37 c for 
25 hours, the starting material and the reaction products 
were separated by high voltage paper electrophoresis. The 
spectrum was obtained by locating these materials and 




































D,D-CARBOXYPEPTIDASE ACTIVITY OF THE HYBRID PROTEIN 
Assays were carried out as described in the Methods 
3 
section. [ H]-L-Lys-D-Ala-D-Ala (specific activity, 67.1 
3 
µCi/µmole was used as the substrate. Release of [ H]-L-
Lys-D-Ala was followed with time by high-voltage paper 
electrophoresis. The following proteins have been assayed : 
the hybrid protein in 50 mM Tris buffer (lµg/µl), pH 7.0, 
containing 150 µg/ml of ampicillin ( 0 - D) ; the hybrid 
protein in 50 mM Tris buffer, pH 7.0, in which the 
ampicillin has been dialyzed away during a 5-hour period 
(~-/~); the wild-type beta-lactamase and the T71I, F72T 




N ~ m CD 0 




~ ~ ' 
\ ' \ ' b a> t> 
\ \ 
\ \ 
- \ \ N \ 
::J"" 
\ \ 
0 \ \ c - \ \ """"m 
CJ) \ \ 
N \ \ 
0 ' 
CJ\ 
' \ N I \ ~ I \ C\ I \ 
N I \ a> 
I \ 
(>J I \ 
N t>f p 
TABLE II 
SPECIFIC ACTIVITY OF THE HYBRID PROTEIN, 
RTEM-1 BETA-LACTAMASE AND PBP5 OF E. coli. 
substrate hybrid protein •PBP5 'RTEM-1 beta-lactamase 
JH -L-Lys-D-Ala-D-Ala ).5x10-Jmin-l o.19min-1 ~------
benzylpencillin 1.)2sec-l 1.5xiu-Jsec-l l?OOsec-1 






THE PH PROFILES OF THE D,D-CARBOXYPEPTIDASE 
ACTIVITY OF THE HYBRID PROTEIN AND PBP5 
OF ~ COLI (upper right corner) 
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C-NMR OF MONOCLONAL ANTIBODIES 
13 
CONTAINING C-ENRICHED TRYPTOPHAN 
121 
INTRODUCTION 
One of the most characterized effector functions 
mediated by immunoglobulins is the triggering of the 
complement cascade (1). Complement consists of a group of 
nine proteins. These proteins, when triggered by antibody-
antigen complexes, can produce a variety of results 
including the elaboration of chemotactic factors, cell 
lysis and viral inactivation (2). The precise mechanism by 
which the binding of antigen triggers this system is 
controversial, and two models have been advanced. One of 
these postulates that antigens act by aggregating 
antibodies. Such aggregation can have two effects. It can 
cause pre-existing sites on individual molecules to be 
brought together. Alternatively, new sites may result (or 
pre-existing sites may disappear), as a consequence of the 
polymerization of the antibodies (3, 4). The other model 
postulates that antibodies are allosteric proteins and that 
antigens function as allosteric regulators in addition to 
aggregating antibody molecules into complexes or clusters 
that function allosterically (4, 5, 6, 7). 
Much evidence has been accumulated to support the 
contention that binding of antigens has an effect on an 
antibody at some distance from the binding site. Using 
neutron and an X-ray small-angle scattering technique, Cser 
122 
et al. have demonstrated that after binding to the 
haptens, pig antibody shows a conformational change (8). 
The results obtained by Liberti et al. (9) also indicate 
that a ligand can induce a conformational effect at some 
distance from the combining site. Additionally, it has 
been found that reduction of the inter-heavy chain 
disulfide bonds, which is known to eliminate complement 
fixation (10), also abolishes circular dichroism changes 
known to originate in the Fe region, which take place when 
antigen is bound (11). A study utilizing the technique of 
circular polarized luminescence (CPL) found changes in the 
CPL spectrum of rabbit antibodies to pneumococcal type III 
polysaccharide when large fragments of the antigen were 
bound, but not with smaller fragments (12). 
Although Wright et al.(13) have prepared dimeric, 
trimeric and tetrameric complexes of IgG and have 
demonstrated that these complexes of IgG alone can activate 
complement fixation by the classical pathway, further 
studies by Sand (14) indicate that under certain 
experimental conditions components C5 to C9 are still not 
activated. Furthermore, it has been confirmed by Hardy 
that monovalent antigen can enhance the complement fixation 
of a monoclonal dansyl-specific IgM (15). This result led 
us to study the possibility of detecting directly the 




The highly sensitive technique of c nuclear magnetic 
resonance (16) provides a very useful probe of protein 
microenvironments (17). Using myeloma cells growing in 
13 
culture (18), one can incorporate a c-enriched amino acid 
into antibodies (19). This approach produces a minimal 




of observing the signals. The natural abundance 
is so low that, coupled with the inherent low 
intensity of the signals, the observation of a few carbons 
at a concentration of 0.1 millimolar would be extremely 
difficult (20). In addition, the background signal from 
all the other protein carbons would tend to obscure any 
specific resonance (21). Enrichment serves both to improve 
the signal-to-noise ratio and to diminish background noise 
relative to the enriched signal. 
13 
Tryptophan enriched in c at the gamma carbon was 
chosen to be incorporated into antibodies for the 
following reasons. First, to minimized spectral 
complexity, it is preferred to label an amino acid which is 
one of the less frequently occurring ones in proteins; 
tryptophan is the least common amino acid residue in most 
proteins (22). Secondly, it is important to consider that 
the probe we used in detecting the conformational changes 
in antibodies should be in a position likely to sense any 
changes that take place; the evidence described below 
indicates that both the gamma carbon in tryptophan and the 
124 
tryptophan residue itself in antibodies are very sensitive 
to their enviromental changes. Previous studies (23) have 
shown that the solvent exposure of tryptophan in IgG 
changes depending on whether antigen is bound or not. It 
has also been shown that labeling of tryptophan differs 
for an antibody and for an antibody-antigen complex (14). 
Moreover, the gamma carbon in tryptophan is a quaternary 
carbon and it is known to shift over five parts per million 
depending on its environment (24). Also, because this 
carbon has no directly bonded hydrogens, one may accumulate 
a spectrum without proton-decoupling and so diminish the 
background resonances relative to the quaternary carbons 
( 25) • An additional advantage of the gamma carbon is that 
its resonance is outside both the aliphatic and aromatic 
envelopes of resonances, further reducing interference by 
either antibody or antigen background resonances. 
In this work, I optimized the tissue culture conditions 
13 
for incorporating c-enriched tryptophan into antibodies. 
Using 
14 
c-tryptophan, I demonstrated that tryptophan will 
not convert to other amino acid residues under these 
culture conditions. The activities of immunoglobulins 
purified by two different procedures have been compared. 
13 
Finally, preliminary NMR spectra of IgG containing c-
2a 
enriched tryptophan have been obtained. 
125 
MATERIALS AND METHODS 
CULTURE CONDITIONS 
Myeloma cells were cultured either in Dubecco's modifed 
Eagle's medium (DMEM) or in RPMI1640 medium supplemented 
with either 10% fetal calf serum or 10% horse serum (Flow 
Labs, Inglewood, CA.). The medium was made up with double 
glass distilled water using a commercial powder formulation 
(Grand Islang Biological Co., Santa Clara, CA.) and then 
sterilized by pressure filtration through a 0.2 micron pore 
filter (Bio-Rad, Richmond, CA.). Labeling medium was made 
up from individual components without L-tryptophan 
according to either modified RPMI1640 or DMEM formulation. 
Just prior to use, 20 milligrams of enriched L-tryptophan 
were dissolved in 5 milliliters of saline solution and 
pressure-filtered into one liter of labeling medium. Prior 
to labeling, cells were grown in 250 milliliter screwcap 
0 
glass erlenmeyer flasks at 37 C in a humidified, 10% carbon 
dioxide-gassed incubator (Lab line 715). Large suspension 
cultures were grown in 2.8 liter flasks containing 1.5 
liter of labeling medium supplemented with 10% fetal calf 
serum and stirred with a "floating" stir bar (Nalge, Ace 
Scientific, Linden, N.J.). 
ISOLATION OF ENRICHED IgG ANTIBODIES 
(1) From Affinity Column 
126 
The spent culture medium was centrifuged to remove 
cells and then applied directly to a DNP-Sepharose 4B 
column. Prior to each use, the column was washed with 20% 
acetic acid and then equilibrated with PBS. After the 
effluent was protein-free (as determined by the absorbance 
at 280 nm) the antibody was specifically eluted with 0.05 M 
DNP glycine. The protein fractions were pooled and a ten-
fold molar excess of sodium dithionite was added with 
stirring to the solution buffered at pH 8.0 with 50 
millimolar Tris. The dithionite reduced the bound DNP as 
observed by the disappearance of the yellow color and was 
immediately removed by pressure dialysis using PBS as the 
replacement buffer. The solution was concentrated to 20 
milligrams per milliliter in deuterated PBS and then 
centrifuged to remove precipitated protein (5000 xg for 10 
minutes just prior to NMR study. 
(2) From Ammonium Sulfate Precipitation Method 
Tris buffer (0.05 M) was obtained by diluting 0.5 M 
Tris buffer, pH 8.3. Two liters of culture supernatant 
were concentrated to 200 ml (original serum volumes). 
Aliquots of one hundred milliliter saturated ammonium 
sulfate, pH 7.8, were added drop by drop into concentrated 
0 
medium with stirring at 4 c. The precipitate was collected 
after two hours by centrifuging the solution at 10 Krpm 
(RC2B rotor) for 10 minutes and then resuspended in a 
minimum amount of 50 rnM Tris and eluted with a linear salt 
127 
gradient to 0.6 M NaCl. That protein eluted in the first 
peak was pooled; its purity was examined by 12% SDS gel 
electrophoresis; the concentration of the protein was 
determined by absorbance measurement assuming an extinction 





A standard microcomplement Cr release assay was 
employed in the complement fixation studies with a few 
modifications (15). The buff er used in all studies was 
hepes-buffered saline (0.01 M HEPES, 0.15 M NaCl, 0.15 mM 
CaCl, 0.50 mM MgCl, 0.1% gelatin, pH 7.40). Hemolysin 
2 2 
and sheep red blood cells were purchased from Flow Labs 
(Inglewood, Calif.). Hemolysin incubation was for 1/2 hour 
0 0 
at 37 C followed by 1/2 hour at O c. Cells were then 
washed three times with Hepes-buffered saline and 
standardized as in the original reference. As has been 
found with some other IgM preparations above a certain 
concentration, large amounts of complement were 
spontaneously fixed, which limited concentrations in these 
assays to 10 µg/well (or 80 µg/ml). 
Briefly, the antibody in 25 µl was added to the various 
dilutions of antigen in 25 ul, complement (2 CH units) 
50 
was added in 25 µl, and the 96 well plate was incubated at 
0 
37 c for 45 minutes. Controls included wells containing 
just the antigen dilutions plus complement, just the 
128 
antibody plus complement, just complement, just the buffer 
and a 100 percent lysis standard of water. 
minute incubation, 50 µl of 2% activated 
After the 45 
51 
Cr loaded-
erythrocytes were added to each well and the plate was 
0 
again incubated for 45 minutes at 37 c. At the end of this 
time the plates were centrifuged using plate holders (Flow 
Labs, Inglewood, Calif.) in a GLC-2 centrifuge (Sorvall) 
0 
for 10 minutes at 2,200 rpm at 4 c. Aliquots of 50 µl per 
well were withdrawn and counted in gamma counter vials on a 
51 
Beckman Gamma 4,000 Counter using the standard Cr 
isoset. 
All complement assays and titrations were carried out 
in Microtiter 96 well plates (Flow Labs, Inglewood, 
Calif.). Pipetting was carried out with Gilson automatic 
pipettors of 20, 200 and 1,000 µl maximum capacity and a 
Pipetteman pi pet tor of 5,000 µl maximum capacity. 
Incubations were carried out in a Lab Line 715 co -100% 
2 
humidity incubator. 




was hydrolyzed by a previously published 
procedure with slight modifications. Hydrolysis was 
performed in a small culture tube (Kimble, 6x50 mm), which 
was put into a thick-walled sealed tube (Pyrex, 80xll mm). 
Two milligrams of protein were hydrolyzed with 40 µl of 3N 
mercaptoethane sulfonic acid in the small culture tube and 
200 µl of 3N mercaptoethane sulfonic acid in the large 
129 
0 
sealed tube at 110 C for 24 hours. After hydrolysis, the 
tube was cooled, opened and 78 µ1 of lN NaOH were added to 
the solution to bring the pH value up to 3.6. Aliquots of 
50 ul were used for the amino acid analysis. 
AMINO ACID ANALYSIS 
A Beckman 120B amino acid analyzer was used. Fifty-
microliter aliquots obtained from the procedure were 
applied to a 0.6x40 cm Aminex AS column and eluted with 
0 
three different buffers sequentailly at 58 c. They are 2N 
sodium citrate (pH 3.2), 2N sodium citrate (pH 4.2) and 
1.2N sodium citrate, lM NaCl (pH 8.9). 
was kindly done by Mr. John Raes.) 
PAPAIN DIGESTION OF IgG 
2a 
(This experiment 
The protein was digested according to the method of 
Porter (26). Papain (0.2 mg) was added in 10 ml of buffer 
(0.05 M sodium acetate, pH 5.5, o.o M cystein, 2mM 
ethylenediamine tetraacetate) containing 20 mg of IgG 
o 2a 
This solution was incubated at 37 c for 15 minutes, 30 
minutes, 1 hour and 1.5 hours, respectively. P-
hydroxymercuribenzoate was added to stop the digestion 
after incubation and dialyzed against water overnight. the 
results were examined by SDS-polyacrylamide gel 
electrophoresis. 
ISOLATION OF Fab AND Fe FRAGMENTS 
The protein was digested as described above for 30 
minutes. After dialysis against water overnight, the 
130 
solution was applied to the DNP-affinity column 
equilibrated with PBS buffer, pH 7.4, and eluted with PBS 
buffer. The first peak was pooled and concentrated to 5 
mL. The concentrated solution was then applied to a G-75 
Sephacel column (2.5x50 cm) equilibrated with PBS, pH 7.4, 
and eluted with the same buffer. The fractions of the 
first peak containing Fe fragment were pooled and examined 
by SDS/polyacrylamide gel electrophoresis. The Fab 
fragment was isolated by the same procedure as described 
for the purification of the intact antibody. 
CELL STORAGE 
Aliquots of cells were frozen in fetal calf serum 
containing 10% DMSO and stored in a liquid nitrogen 
refrigerator. Cells were pelleted and resuspended at 5 x 
6 7 
10 to 1 x 10 cells per milliliter in the freezing medium. 
One-milliliter aliquots were dispensed into 2 ml 
polypropylene freezer vials and the vials placed in a 
styrofoam block (approximately one centimeter of insulation 
around each vial). 
0 
The block was placed in a -70 c 
refrigerator and after 24 hours the vials were transferred 
to the liquid nitrogen refrigerator. Warming the vials in 
0 
a water bath to 38 c and washing the cells to remove the 
DMSO medium restored the cells to a viable state. The 




A Bruker WM-500 (117 KG) and a Varian IX-299 (47 KG) 
13 
were used to observe C spectra. Ten millimeter sample 
tubes with 2.5 milliliter volume were used and were locked 
to an internal DO signal. Protein concentrations were 0.1 
2 
to 0.3 millimolar. At 117 KG, the flip angle we used was 
0 
18 and the acquisition time was 0.557 milliseconds; at 47 
0 
KG the flip angle we used was 12 and the acquisition time 
was 0.2 milliseconds. No decoupling was used. Spectra 




Using c-tryptophan, we have found that RPMI1640 
medium supplemented with 10% fetal calf serum is the best 
culture medium for incorporating this labeled amino acid 
into antibodies. The results are shown in Table 1. Figure 
1 indicates that there is less than 10% conversion of 
tryptophan to other amino acids. The optimal conditons for 
the papain digestion of IgG were established; the results 
2a 
are shown in Figure 2. After the papain digestion of 
IgG , the Fe and other small fragments were separated from 
2a 
the Fab fragment by the use of an affinity column. The Fe 
fragment was separated from the other small fragments on a 
G-75 column. The results are shown in Figure 3. Figure 4 
shows the elution profile of IgG on a DEAE Sephacel 
2a 
column. Figure 5 shows the comparison of the activity of 
antibodies purified by the ammonium precipitation method 
and by the affinity column. Figures 6 and 8 show the 
spectra of intact IgG and its Fab fragment. Figure 7 
2a 
shows the difference spectrum obtained from the subtraction 







Using C-tryptophan, I have found that modified 
RPMI1640 supplemented with 10% fetal calf serum is the best 
culture medium for incorporating enriched tryptophan into 
antibodies. The differences between the formulation of 
DMEM and modified RPMI1640 are discussed below. In modified 
RPMI1640, HEPES is the major buffer material. It contains 
more vitamins than DMEM. They are p-amino benzoic acid, 
biotin and vitamin B12. It also contains hypoxanthin and 
thymidine. In DMEM, however, NaH PO · H O is the major 
2 4 2 
buffer material. 
P-Amino benzoic acid can be used by plants and 
procaryotes, but not by mammalian cells. Biotin 
participates in the conversion of pyruvate to oxaloacetate 
and serves as a carrier for the "active" CO . The detailed 
2 
mechanism of the action of vitamin B12 is still unknown 
( 27) • Hypoxanthin is a purine source; thymidine is a 
pyrimidine source. HEPES is known to be a better buffer 
material for tissue culture. With these poor 
understandings, it is difficult to explain why modified 
RPMI1640 is a better medium than DMEM for incorporating 
13 
c-enriched tryptophan into antibodies. It is also very 
difficult to explain why fetal calf serum is better than 
134 
dialyzed horse serum. However, the optimal 
conditions for incorporation have been found. 
growth 
Modified 
RPMI1640 suplemented with 10% fetal calf serum was always 
used as the culture medium after this finding. 
Furthermore, amino acid analysis gave recoveries of more 
14 
than 90% of the c-tryptophan, indicating that little 
conversion of it to other 
PURIFICATION OF LABELED IgG 
2a 
amino acids occurs. 
To obtain free DNP-specif ic antibodies purified by the 
affinity column, we have to use sodium dithionite to remove 
the DNP-glycine which bound tightly to the antibodies. 
Although there is only a small difference between the 
activities of the antibodies purified by the affinity 
column and those purified by the precipitation method, we 
prefer using a method with the least danger of perturbing 
the conformation of the intact antibody. At the same time, 
five new cell lines have been obtained from Dr. 
Herzenberg's Laboratory. All of these new cell lines 
produce dansyl-specific immunoglobulins. Since we may face 
the same problem when purifying these immunoglobulins by an 
affinity column, a more general method of purification of 
antibodies is desirable. 
A DEAE-Sephacel column has been found to be a better 
ion exchange column for purifying the antibody than DEAE-
cellulose column (14). The exact procedure has been 
described in the Methods section. Antibody was precipitated 
135 
from the supernatant by ammonium sulfate; the crude 




All of the C spectra were accumulated with a very 
small flip angle because the T
1 
for tryptophan resonance at 
high fields is very long. The value of T
1
can be calculated 




+ i;rf SA i;i£SA can 
1 • 1 
be calculated from the following equation : 
CSA 2 2 2 2) 
I I Tl = (2 /15)H 0/ (6cr) TR(I +/ H0 TR ( 25) • 
Here, is the gyromagnetic ratio; Ho is the magnetic field 
strength. l/TD1 can be calculated from the following . 2 2-6 
equation : I IT~=~ I /T1j =(2/i 5)fi-Yc Pt(Stl )'j re J X. (24). 
Here, l/Tij is the contribution to l/T1 from a dipolar 
13 
interaction between the pertinent c nucleus 





of nucleus j, respectively, Sj is the spin quantum number 
of nucleus j, each cj represents a nonbonded c-j distance, 
and x.= Ti 3 TR 6 Tg 
I + ( w. - CJ )2 ,2 + I +ufc1p; 
+ 
( 2 2 I I+ Wj+wc) TR J J c F<. 
Here, We and Wj are the resonance frequences, in 
13 
radians/sec., of c and of nucleus j I respectively; TR. is 
the correlation time for rotational reorientation of the 
molecule. Using the estimate value of of about 150 
nanoseconds {15), we can estimate values of T1 • At 47 KG 
{Varian XL-200), the T
1 





is about 14 seconds. At 117 KG (Brucker 500), the 
shift anisotropy dominates the relaxation 
mechanism of the nonprotonated unsaturated carbons in a 
native protein (25), and the T 1 is about 20 seconds. 
According to these values of Tt , the best flip angle can 
be calculated at a fixed acquisition time. After several 
tests, the optimal conditions for accumulating the spectrum 
of intact IgG were found. At 47 KG, the flip angle we 
o 2a 
used was 12 and the acquisition time was 0.2 milliseconds; 
0 
at 117 KG, the flip angle we used was 18 , and the 
acquisition time was 0.557 milliseconds. 
The preliminary spectra of IgG and its Fab fragment 
2a 
obtained under these conditions are shown in Figures 6, 7 
and 8. Unfortunately, although I have used the optimal 
13 
conditions for incorporating the c-enriched 





enriched IgG , 
2a 
the signal-to-noise ratio of the spectra I 
obtained are still not very good. This is because the 
for tryptophan resonance is too long and, to avoid 
saturating the resonance, we have to use a very small flip 
angle. This problem won't be solved even when we use an 
NMR with higher magnetic field because, at a higher 
magnetic field, the chemical shift anisotropy dominates the 
relaxation mechanism of the nonprotonated unsaturated 
carbons in a native protein causing T 1 to become yet longer 
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TABLE I 
NUMBER OF MOLECULES OF 14c-TRP INCORPORATED 
INTO ONE MOLECULE OF IgG2a 
Modified RPM! 1640 
& 10.96 
10% Fetal Calf Serum 
------
Modified RPMI : l640 
& 6.36 
10% Dialyzed Horse Serum 
DMEM & 10% Fetal Calf Serum 5.37 
. 





















































12% SDS/PAGE OF IgG DIGESTED BY 
2a 




12% SDS/polyacrylamide gel electrophoresis 
of IgG digested by papain for 15, 30, 60 
2a 
and 90 minutes, respectively. 
12% SDS/polyacrylamide gel electrophoresis 
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THE ELUTION PROFILE OF Fe AND OTHER SMALL 
FRAGMENTS, OBTAINED BY DIGESTION OF IgG 
2a 
ON G-75 SEPHADEX COLUMN 
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THE ELUTION OF PROFILE OF IMPURE IgG 
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COMPLEMENT FIXATION OF IgG 
2a 
0: purified by (NH ) SO precipitation method 
4 2 4 o: purified by the affinity column 
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THE SPECTRA OF ( - C-Trp ENRICHED IgG 
2a 




/- C-Trp enriched IgG (0.8 mM) 55,129 
2a 
transients at 125 M Hz. 
13 
Fab fragment of/- C-Trp enriched IgG 
2a 














AND ITS Fab FRAGMENT 
The difference spectrum of those two 
spectra shown in Figure VI. 
13 
{- C-Trp enriched IgG 55,129 transients 
2a 













ITS Fab FRAGMENT AT 50 M Hz 
13 
/- C-Trp enriched IgG (0.8 mM) 222,885 
2a 
transients at 50 MHz. 
13 
Fab fragment of/- C-Trp enriched IgG 
2a 




STUDIES OF THE MECHANISM OF 
NUCLEAR ACCUMULATION OF PROTEINS 
158 
The nuclear and cytoplasmic compartments of eukaryotic 
cells contain large distinct sets of proteins (1, 2). 
Studies of the fate of endogenously synthesized and 
exogenously introduced proteins suggest that all nuclear 
proteins are synthesized in the cytoplasm, from which the 
mature polypeptides migrate rapidly to the nucleus (3, 4, 
5, 6) • Thus the steady-state segregation of the proteins 
between nucleus and cytoplasm appears to be governed by an 
intrinsic property of mature polypeptides. It is not clear 
how the structures of proteins specify their distribution 
between the two compartments. 
Several models have been commonly used to explain the 
nuclear accumulation of certain proteins (7, 8, 9, 10). 
The first envisages the free diffusion of all proteins into 
the nucleus with the subsequent retention of nuclear 
proteins by their binding to nondif fusible nuclear 
elements. The second model suggests that the accumulation 
of nuclear proteins is due to their selective transport 
across the nuclear envelope. The third model suggests that 
both selective transport and selective binding play a role 
in nuclear accumulation. This model also suggests that it 
is possible that these two activities are controlled by 
different regions of the protein. 
since nuclear accumulation is selective and occurs 
posttranslationally, it has been proposed that nuclear 
proteins contain within their mature molecular structure a 
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signal sequence that controls their accumulation (2, 3, 7). 
In the first model, this signal would be responsible for 
the nuclear retention of the protein, while in the second 
model its interaction with the nuclear envelope would allow 
selective transport of the protein into the nucleus. 
Experimental evidence, however, suggests that neither the 
first model nor the second model is wholly correct. If all 
proteins entered nuclei by free diffusion, then assuming a 
0 
functional nuclear pore radius of 45 A for the Xenopus 
oocyte nucleus (11), one would predict that, for these 
nuclei, proteins with mol. wt. larger than 70,000 daltons 
would be excluded and proteins smaller than this would 
enter freely. However, many nuclear proteins that are 
considerably larger than 70,000 daltons can enter nuclei at 
a rate faster than predicted (1, 3). Evidence against 
protein accumulation by selective transport across the 
nuclear envelope is based on experiments which show that 
the puncture or removal of the nuclear envelope has little 
effect on the ability of the nucleus to accumulate nuclear 
proteins (8, 11). 
Recent studies favor the third model (10, 12). The 
sequence responsible for the nuclear accumulation of the 
influenza virus nucleoprotein in Xenopus oocytes has been 
identified (10). When the globin cDNA is fused to a 
portion of cDNA of NP including the region encoding amino 
acids 327-345, the resulting fusion protien enters and 
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accumulates in the nucleus. Fusion proteins lacking this 
region of the NP enter but do not accumulate in the 
nucleus. Despite these findings, they have not identified 
another signal peptide that is responsible for nuclear 
entry of the NP. 
Furthermore, a short sequence of amino acids including 
Lys-128 has been demonstrated to be required for nuclear 
accumulation of SV40 large T antigen (12). The implication 
that the sequence element around Lys-128 acts as an 
autonomous signal capable of specifying nuclear location 
has been tested directly by transferring it to the amino 
termini of beta-galactosidase and of pyruvate kinase. They 
are normally cytoplasmic proteins. Sequences that include 
the putative signal can induce each of the fusion proteins 
due to to accumulate completely in the nucleus. However, 
the absence of the kinetic data of nuclear entry of these 
fusion proteins, it is still unclear whether this sequence 
is responsible for either nuclear entry or specific binding 
to nondiffusible nuclear elements, or it is responsible for 
both. 
To further study whether both selective transport and 




these two activities are controlled by different 
of the proteins, the following experiments are 
It has been demonstrated that Pro-Lys-Lys-Lys-Arg-Lys-
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Val can act as a nuclear location signal (12). However, it 
is still unclear whether this sequence is responsible only 
for nuclear entry. This can be studied by first isolating 
the fusion protein of beta-galactosidase and this signal 
sequence that has been produced by E. coli, then 
microinjecting the isolated fusion protein into the 
cytoplasm of Xenopus oocytes and finally detecting the rate 
of nuclear accumulation of the injected fusion protein. 
If this fusion protein accumulates in the nucleus of 
Xenopus oocytes much faster than the intact beta-
galactosidase, we can conclude that this signal sequence is 
responsible for nuclear entry. However, this result still 
can't tell us whether this signal sequence is also 
responsible for selective binding in the nucleus of Xenopus 
oocytes because of the large size of the fusion proteins 
that could not diffuse out of the nucleus once they 
entered. To further study this question, we can make a 
series of deletions of the gene encoding the fusion 
protein. We can then obtain a series of fusion proteins 
that contain different parts of beta-galactosidase but the 
same signal peptide. 
With these fusion proteins, we can study the rate of 
their entry into the nucleus of Xenopus oocytes as 
described above. The results obtained from this study may 
provide evidence for the effects of the conformation and 
the size of the fusion proteins on the rate of their nuclei 
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entry. With these fusion proteins we can also study the 
effects of the size of the fusion proteins on the amount of 
their nuclear accumulation. The results obtained from this 
study may provide evidence for the role of the single 
sequence in specific binding in the nucleus of Xenopus 
oocytes. 
As I described at the beginning, it has also been 
demonstrated that a short amino acid sequence from 327 to 
345 is responsible for nuclear accumulation of the 
influenza virus nucleoprotein (NP) in Xenopus oocytes (10). 
It has been suggested that this sequence is responsible for 
the specific binding to nondiffusionable elements in the 
nucleus of Xenopus oocytes. We can use the same approach I 
proposed above for studying whether this sequence is 
responsible for specific binding alone. First, we can fuse 
the gene of beta-galactosidase with that encoding the amino 
acid sequence from 327 to 345 of the influenza virus 
nucleoprotein at either the 5 1 -end or the 3'-end. The 
fusion proteins can be produced by E. coli, then be 
isolated and microinjected into the cytoplasm of Xenupos 
oocytes. If this sequence is responsible for specific 
binding to the nucleus elements alone, these fusion 
proteins will not be able to enter the nucleus because of 
their large size. We can then make a series of deletion of 
the genes encoding the fusion proteins. After these fusion 




the cytoplasm of the Xenopus oocytes, the rate of 
nuclear entry and the amounts of their nuclear 
accumulation can then be studied. The results obtained 
from this study may provide evidence for the role of this 
specific sequence in nuclear entry and nuclear 
accumulation. 
Finally, we can construct a series fusion proteins that 
contain parts of beta-galactosidase, the signal sequence, 
Pro-Lys-Lys-Lys-Arg-Lys-Val, and the amino acid sequence 
from 327 to 345 of the NP. Again, we can study the rate of 
nuclear entry and the amount of nuclear accumulation of 
these fusion proteins using the same approach as I decribed 
above. Combining all the results obtained from these 
studies, we may gain further insights into the ideas that 
both selective transport and selective binding play a role 
in nuclear accumulation and that these two activities may 
be controlled by different regions of nucleoproteins. 
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THE RELATIONSHIPS BETWEEN THE HINGE REGION AND 
THE BIOLOGICAL FUNCTIONS OF ANTIBODIES 
166 
IgG is a divalent molecule of mol. wt. 150,000. 
Antigen is recognized by sites on the Fab domain of the 
molecule. A number of molecules involved in triggering 
effector functions, however, interact with sites on the Fe 
domain of the molecule. These include complement 
subcomponent Clq, Cls, complement component C4 and Fe 
receptor molecules (1). It is generally agreed that Clq 
interacts with the C2 domain of IgG, but the precise 
location of the Clq-binding site is still a matter of some 
controversy (2). Complement subcomponent Cls is thought to 
occupy the extremities of a very extended Cly Cls 
I 2 2 
molecule, and its interaction with a site on IgG has still 
to be definitively demonstrated (3). Activated complement 
component C4b is thought to form a covalent linkage to a 
lysine on the Fab arms of IgG, possibly in the V'Y domain 
(2). Activated C3b forms a covalent linkage to a residue 
in the v'Y or T domain ( 4) . The involvement of both C 1 2 
and c"Y 3 domains in the interaction with Fe receptor 
molecules have been claimed (5). The extent to which the 
receptor molecules from different cell types are 
overlapping or identical sites on IgG is unkown. 
The molecular structure of IgG is now known in some 
detail. High-resolution crystal structures are available 
for pooled human Fe (6), rabbit Fe (7), guinea pig pFc (8), 
human Fab New (9) and Kol (10). Due to the flexibility of 
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the hinge region (1), complete structures are available 
only for the hinge-deleted IgG, proteins Dob (11) and Meg 
(12). The lack of information on the relative dispositions 
of Fab and Fe in an intact IgG molecule, which may be very 
important in revealing or masking binding sites, is 
probably the most serious gap in our understanding of IgG 
structure. 
Although there are probably no functional binding sites 
in the hinge region, this structure unit seems to be very 
important in modulating such sites existing in other 
structural domains of antibodies. Because of the lack of 
information on the complete three-dimensional arrangement 
of the heavy-chain residues between Fab and Fe for even a 
single hinge conformation, we do not know with any 
certainty the pivotal area about which Fab-Fc relative 
movement occurs or the degree of such movement allowed in a 
given case. These factors may be crucial in modulation of 
functional sites (1). 
It is well known that the isotypes shown in Table 1 
can express different biological activities (14, 15). The 
human IgGl and IgG3 are more effective at activating 
complement and binding to cell receptors than IgG2 and 
IgG4; mouse IgGl and guinea pig IgGl are much less 





or rabbit IgG [reviewed in (13) and (14)]. The idea 
the hinge can modulate biological activity comes from 
168 
a combination of observations. First, sequence differences 
in 
the 
the y or Cj3 domains have not been found 
subclass specificities described above. 
to explain 
Second, the 
greatest differences between the subclasses are located in 
the hinge. Third, hinge-deleted proteins tend to show 
diminished biological activities [reviewed in (5)]. Here, 
to obtain convincing evidence for the view that the hinge 
region can modulate the biological functions of antibodies, 
I propose to generate a series of systematically designed 
mutant IgGs that contain exactly the same Fab and Fe 
domains but different hinge structures. 
With the advent of the development of hybridoma and 
recombinant DNA technology, we can now manipulate 
immunoglobin genes in vitro and then transfect them into 
lymphoid cells (18). The transfected genes can be 
faithfully expressed, and assembly can occur between the 
transf ected and endogenous chains or between two 
transfected chains (5). Once the immunoglobulin genes have 
been cloned in a suitable vector, one can replace any 
specific fragment of the cloned gene with another designed 
synthetic oligonucleotide duplex when suitable endonuclease 
restriction sites are available. Thus, we can generate a 
series of chimeric genes encoding chimeric antibodies that 
contain exactly the same Fab and Fe domains but different 
hinge structures. 
The most commonly used vectors have been the pSV2 
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vectors (15), in which the selectable marker is placed 
under the control of the SV40 early promoter; SV40 
sequences provide slice signals and a polyadenylation site. 
Two selectable bacterial genes have been used (i) the 
xanthine-guanine phosphoribosyltransferase gene (gpt) (16), 
and (ii) the phosphotransferase gene from Tn5 (designated 
neo) ( 17) . The recipient cell type chosen for the 
production of Ig molecules would appear to be myeloma 
cells. Once these designed chimeric genes have been 
successfully transfected into the myeloma cells, these 
designed chimeric antibodies can then be isolated either 
from tissue culture or from the ascites of tumor-bearing 
mice. 
The gene encoding the 1'2b heavy chain of the myeloma 
MPC-11 has been successfully transfected into the myeloma 
J558 (19, 20). This f 2b heavy chain has been expressed, 
assembled with the endogenous chain, and secreted as H L 
2 2 
molecules (19, 20). By the use of cassette mutagenesis, 
the gene segment encoding the hinge sequence of the 2b 
heavy chain can be replaced by different gene segments 
encoding the hinge sequences of human fl, f2, J4, mouse 'Y1, 
as shown in Table l. After these designed chimeric 
genes in the pSV40 vector have been transfected into the 
myeloma J558 cells and the myeloma J558 cells containing 
the pSV40 vector can be selected as described (16, 17), the 
chimeric antibodies can then be isolated either from the 
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tissue culture of the selected myeloma J558 cells or from 
the mice bearing the tumor of the selected myeloma J558. 
Finally, the effectiveness of these chimeric antibodies at 
activating complement can be assayed. 
This study may provide evidence for or against the 
view that the hinge structure can modulate the biological 
functions of antibodies. Furthermore, the flexibility of 
these chimeric antibodies can be measured by the use of 
nanosecond fluorescence (21, 22). This further study may 
provide us insights into the relationships between the 
flexibility and the biological functions of antibodies. 
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TABLE I 
A COMPARISON OF HINGE SEQUENCES 
216 238 
Human Y1 E P K S C D K T H T • C P P • . . . . • C P A P E L L G G P 
Human Y2 E R K • . . . . . . • C C V E C P P • • C P A P P V A G . P 
Human Y4 E S K Y G • . . • p p c p p • . . . . • C P A P E F L G G P 
Mouse Y1 V P R D C G • . . . • C K P C i . . . • C T V P • • E • V S 
--· 
Mouse Y2a E P R G P T I K • • P C C P P K . . . • C P A P N L L G G P 
Mouse Y2b E P S G P I S T I N P C P P C K E C H K C P A P N L E G G P 
1' 1' 
First S-S Last S-S 
A dot indicates that the alignment chosen produces no residue corresponding 






ElA TRANSCRIPTION INDUCTION 
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The adenovirus ElA gene encodes products that function 
in the modulation of gene transcription initiation and in 
the oncogenic transformation of mammalian cells (1). At 
early times following viral infection, the human subgroup-c 
adenovirus (adenovirus type-2 and -5) ElA gene produces 
two mRNAs, designated 12S and 13S, which result from 
alternative RNA splicing of the primary transcript (2). A 
set of five viral promoters are coordinately regulated by 
these ElA gene products. In addition, two cellular 
promoters, hsp70 and beta-tubulin, are also stimulated by 
the action of these ElA gene products (3, 4, 5). Recently, 
the mechanism for this transcriptional induction has been 
investigated with an in vivo exoIII mapping technique to 
assay for proteins that interact with an ElA-inducible 
promoter (6). A protein bound to the early E2 promoter has 
been detected in wild-type infected cells. In the absence 
of ElA induction, specific interactions at the promoter 
could not be detected. However, if conditions were 
established that allowed transcription of the E2 gene in 
the absence of ElA, the same exoIII protection was observed 
as was found in the presence of ElA, suggesting a model in 
which the efficient utilization of the E2 promoter is 
mediated by a cellular transcription factor. Despite this 
finding, the precise mechanism by which the complexes of 
the cellular transcription factor and the ElA gene products 
activate the transcription of the E2 gene remains 
176 
unknown. 
Many regulatory proteins have been found. These 
proteins bind at specific DAN site and influences the 
transcription of a gene hundreds or even thousands of base 
pairs away 
of these 
(7). Recent experiments suggest a unified view 
apparently disparate types of gene regulation. 
First, regulatory proteins recognized specific sequences in 
DNA using structures that are complementary to the ordinary 
helix. Second, DNA-bound regulatory proteins influence 
transcription by excluding binding of other proteins or, 
more generally, by touching another DNA-bound protein (7). 
Under the assumption that this view can be applied on the 
complexes of the cellular transcription factor and the ElA 
gene products, I postulate that in the complexes, the 
cellular transcription factor could play a role in DNA 
binding, and the ElA gene products could play a role in 
the interaction with another protein,the RNA polymerase. 
These complexes can thus activate the transcription of 
certain genes that are under the control of the promoters 
recognized by the cellular transcription factor. 
It has been demonstrated that ~ coli expressed ElA 
proteins will undergo a posttranslational modification and 
then function normally in microinjected Xenopus oocytes 
(8). It has also been demonstrated that the DNA binding 
function of GAL4, a Saccharomyces cerevisial 
transcriptional activator, can be replaced with that of a 
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prokaryotic repressor without loss of the transcriptional 
activation function (9). This is done by the construction 
of a hybrid protein of GAL4 and Lex A, an ~ coli repressor 
protein. The hybrid protein, synthesized in yeast, 
activates transcription of a gene if and only if a Lex A 
operator is present near the transcription start site, 
leading to the conclusion described above. Similarly, to 
test the postulation that the ElA gene products could play 
a role in the interaction with the RNA polymerase, we can 
construct a gene-encoding hybrid protein of Lex A and an 
ElA gene product using pBR322 plasmid. The hybrid protein 
can then be isolated in E. coli and microinjected into the 
cytoplasm of Xenopus oocytes that have already been 
microinjected with a chimeric gene (Lex A-CAT) containing 
the Lex A operator linked to the CAT coding sequence (8). 
The level of CAT enzyme activity can then be messured (8). 
If this hybrid protein can activate the transcription of a 
gene only when a Lex A operator is present near its 
transcription start site, we can then conclude that the 
ElA gene product indeed plays a role in the interaction 
with another protein, most likely to be the RNA polymerase. 
In other words, these proposed experiments may provide us 
valuable evidence for the view that the ElA gene products 
can activate the transcription of specific genes by 
contacting the RNA polymerase after they bind to the 
cellular transcription factor. 
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PROPOSITION IV 
STUDIES OF THE STRUCTURE-FUNCTION RELATIONSHIPS 
BETWEEN CLASS A BETA-LACTAMASES AND CLASS C 
BETA-LACTAMASES BY MUTAGENESIS 
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Beta-lactamases can catalyze the hydrolysis of the 
amide bond in the beta-lactam ring of penams and cephems. 
These enzymes have been classified into three groups, class 
A, B and c. Class A beta-lactamase that has molecular 
weights of around 29,000 show significant amino acid 
sequence homology among themselves (1, 2), and 
preferentially hydrolyze penam antibiotics. Class B beta-
lactamase is a metalloenzyme of molecular weight 23,000, 
which attacks cepham antibiotics and is produced only by 
Baccilus cereus (1). Class C beta-lactamases, however, are 
chromosomally determined cephalosporinases of E. coli. 
They are larger proteins (mol wt. 39,000). 
It has been proposed that these beta-lactamases may 
be evolutionarily related to D,D-carboxypeptidases that are 
involved in the peptidoglycan cross-linking in cell wall 
synthesis (3). Recent discoveries of the significant 
similarity between the three-dimensional structures of R61 
D,D-carboxypeptidase and the class A beta-lactamases of B. 
licheniformis 749/C (4), as well as B. cereus 591 (5), 
strongly support the hypothesis described above. In 
Chapter III of this thesis, I further studied the 
structure-function relationships between beta-lactamases 
and D,D-caroxypeptidases by the construction of a hybrid 
protein of RTEM-1 beta-lactamase and PBP-5 of E. coli. 
This study not only provides an evidence which further 
supports the hypothesis described above but also 
181 
demonstrates that by the construction of a hybrid 
one can create a new enzyme with desired 
functions. To further demonstrate the power 




As I described above, class A beta-lactamases 
preferentially hydrolyze penam antibiotics. Class c beta-
lactamases, however, preferentially hydrolyze cephem 
antibiotics. For class A beta-lactamases, both acylation 
by benzylpenicillin and deacylation are rapid. For both 
class C beta-lactamase and certain D,D-carboxypeptidases, 
acylation is more than a million times faster than 
deacylation, and the acyl enzyme accumulates. Despite 
these differences, both class A beta-lactamases and class c 
beta-lactamases possess the important Phe-x-x-x-ser-X-X-Lys 
sequence and catalyze cephalosporin via an acyl enzyme 
intermediate (6). Possibly, these two groups of enzymes 
may share a common evolutionary origin. It has also been 
suggested that the class C beta-lactamases may be expected 
to share some or all of the tertiary structural features 
that have been found to be common to the class A beta-
lactamases and the R61-CPase (5). So, it is worthy of 
constructing a hybrid protein of class A and class C beta-
lactamase to further demonstrate the power of the approach 
and to study the structure-function relationships between 
these two proteins. 
I propose to replace the polypeptide of 29 amino acids 
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of RTEM-1 beta-lactamase, including the active site Ser, 
with the corresponding polypeptide of ampC cephalosporinase 
of E. coli as shown in Table I. The reason for making this 
substitution is that this polypeptide contains most of the 
amino acid residues potentially able to contact the 
substrates. After the gene encoding the hybrid protein 
has been successfully constructed as shown in Figure 1, it 
can then be cloned into pBR322 for checking the resistance 
of the cells containing the hybrid gene to cephem 
antibiotics. 
The in vivo stability of this hybrid protein can also 
be checked by western blot. The hybrid proteins 
constructed in this way are usually not very stable. The 
instability is possibly due to a bad interaction between 
their second structures (7 ,8). This problem may be 
overcome by making further mutations in the hybrid protein. 
Since it would be difficult to predict what mutations we 
should make at this point, random mutagenesis followed by 
selection of desired mutants on agar plates containing 
different concentrations may be a better approach than 
site-specific mutagenesis for obtaining more stable or more 
active mutants of the hybrid protein. These procedures of 
mutation followed by selection can be done repeatedly until 
colonies displaying satisfactory resistant phenotypes 
against cephem antibiotics have been obtained. By 
comparing the catalytic parameters of these mutants of the 
183 
hybrid proteins with the differences in the amino acid 
sequence of these mutant proteins, we may obtain insights 
into the structure-function relationships between class A 
beta-lactamase and class C beta-lactamase. This study may 
also provide further evidence for the view that 
construction of hybrid proteins may create new enzymes with 
desired catalytic functions. 
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FIGURE I . 
THE SCHEME FOR THE CONSTRUCTION OF THE HYBRID GENE 
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BIOLOGICAL FUNCTIONS OF N-ACETYLTRANSFERASES 
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N-terminal blocking of proteins is a widespread 
phenomenon in eukaryotes, prokaryotes and viruses (1, 2, 
3). It has been found that about 80% of the soluble 
proteins from Ehrlich ascites cells are N-acetylated (4) 
and approximately 90% of the proteins from mouse L cells 
seem, also, to be N-acetylated (5). Furthermore, in lower 
eukaryotic organisms, about 50% of the soluble proteins are 
acetylated (6). 
The biological significance 
proteins is still an open question. 
of N-acetylation of 
It has been suggested 
that a general function for N-acetylation is the protection 
of proteins from proteolytic degradation by aminopeptidases 
(7). However, experiments to sustain this hypothesis have 
not shown significant differences in the turnover rate of 
acetylated and nonacetylated forms of feline beta-globin 
and of proteins from mouse L cells (5). The possibility 
that N-acetylation plays a role in protein secretion has 
also been suggested (8). The recent result from DNA 
sequencing has shown that in structural genes, encoding the 
secretory proteins that are N-acetylated, the codon for the 
acetylated amino-terminal residue is directly preceded by 
the initiation codon without the insertion of additional 
codons for amino acids (9). However, little effort has 
been made to understand the relationship between N-
acetylation and transport of secretory proteins. 
The functional role of the N-acetyl group in beta-
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endorphin and alpha-melanotropin is more obvious in 
directly affecting biological activity : in contrast to N-
unacetylated native beta-endorphin, the acetylated peptide 
is nonanalgesic and cannot be bound to opiate receptors in 
vitro (10). Conversely, native alpha-melanocyte-
stimulating hormone (alpha-MSH) is more potent than the N-
deacetylated peptide in causing melanocyte dispersion (11). 
N-acetylation is an enzyme-catalyzed reaction in which 
the protein accepts the acetyl group from acetyl-CoA. The 
N-acetyltransferases have been found in various cells and 
tissues such as rabbit reticulocytes (12), rat liver (13, 
14), rat pituitary (15, 16, 17), calf lens (18), and wheat 
germs (19). The nature of these N-acetyltransferases is 
still unknown. This is due to their low concentration and 
extreme instability after purification. 
To facilitate the study of the biological significance 
of N-acetylation of proteins, it is important to clone the 
genes encoding these enzymes. After a small part of the 
amino acid sequences of one N-acetyltransferase is known, 
we can synthesize a mixed oligonucleotide probe that 
contains all possible DNA sequences encoding the known 
amino acid sequence. Using the mixed probe, we can then 
screen for clones containing a fragment of the gene 
encoding the N-acetyltransferase from the cDNA library. 
Combining the sequencing data and the restriction maps of 
those positive clones, we can obtain the whole DNA sequence 
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encoding the enzyme. Here, I proposed a series of 
experiments as a systematic approach for studying the 
biological functions of the N-acetyltransferase whose gene 
has been cloned. 
The baker's yeast Saccharomyces cerevisiae is one of 
the most suitable systems for initiating this study because 
its genome is small, its generation time is short and it 
can be experimentally manipulated as easily as most 
prokaryotes. 
Once a gene of N-acetyltransferase in yeast is cloned, 
we will know whether there is only one N-acetyltransferase 
or whether there is a group of N-acetyltransferases in 
yeast reponsible for the acetylation reaction of proteins. 
This can be done easily by screening the whole genome 
32 
library by the use of P-labeled fragments of the cloned 
gene followed by checking the restriction maps of the 
positive colonies and finally, by sequencing the DNA 
fragments. 
When there is only one single copy of the gene encoding 
the N-acetyltransferase in the yeast genome, we can study 
the essentiality of this gene using the technique of one-
step gene disruption as shown in Figure 1 (20). The cloned 
DNA fragment containing the gene, designated GENE NAT, 
which encodes the N-acetyltransferase, is digested with a 
restriction enzyme that cleaves within the DNA sequence of 
the GENE NAT. Another DNA fragment containing the HIS 3 
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yeast gene is cloned into the cleaved GENE NAT. The in 
vitro disrupted gene can be liberated from the bacterial 
plasmid sequences by restriction enzyme digestion. The 
digested DNA containing the disrupted gene can be 
+ + 
transformed into a his 3 , GENE NAT yeast cell, and HIS 3 
transformants are selected. Among the transformants are 
+ 
strains that simultaneously become HIS 3 and gene NAT . If 
+ 
we can't obtain any transformants that are HIS3 and NAT , 
we may conclude that the disruption of this gene is lethal 
to yeast cells. The essentiality of this gene can be 
further studied by first disrupting the gene in a diploid. 
Subsequent genetic analysis of the disrupted gene will 
reveal linkage of its lethal function to the selectable 
genetic marker used to disrupt the gene. If the disruption 
of this gene is indeed lethal to the yeast cells, the gene 
product, N-acetylatransferase, must be essential for the 
viability of the yeast cells. In other words, the N-
acetylation of certain proteins is a very important 
modification process in these cells. If, however, the 
disruption of this gene is not lethal to the yeast cells, 
it is possible that the N-acetylation of certain proteins 
has no significant effect on the biological functions or on 
the in vivo turnover rates of these proteins. 
To further study the biological function of N-
acetylation of proteins, the following experiments are 
proposed. First, the GENE NAT can be cloned into a 
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suitable vector such as YEpl3S(21). This vector is a 
derivative of the yeast plasmid 2-µm circle. In this 
vector, the LEU2 gene is used as the selectable marker and 
this GENE NAT can be placed under the control of a promoter 
such as USA (22). The transcription of the GENE NAT can 
G 
thus be regulated by the protein GAL4 (22). Another gene 
encoding a protein that is known to be N-acetylated in 
yeast should also be cloned into the same vector and this 
gene should be expressed constitutively. The gene encoding 
alcohol dehydrogenase isozyme-II (23) can be a good 
candidate for this approach. The vector containing these 
two cloned genes can then be transformed into either a NAT 
+ + 
leu2 gal4 yeast strain or a NAT leu gal yeast strain 
( 21) . 
Comparing the turnover rate 
+ 
dehydrogenase isozyme-II in the gal4 
of the alcohol 
yeast strain in which 
the GENE NAT is fully expressed with that in the gal4 
yeast strain in which the GENE NAT is only partially 
expressed, we may obtain valuable evidence for the effects 
of the N-acetylation of certain proteins on their in vivo 
stability in yeast cells. 
If, however, there are multiple copies of the gene 
encoding this enzyme in the yeast genome, the technique of 
one-step gene disruption could no longer be used for 
studying the biological functions of N-acetyltransferases. 
An alternative approach is proposed below. We can 
194 
construct a vector that contains the gene that encodes 
alcohol dehydrogenase isoenzyme-II and the anti-sense gene 
of the GENE NAT. This anti-sense gene can be placed under 
the control of a regulatory promoter such as USA . Thus, 
G 
the in vivo stability of the alcohol dehydrogenase isozyme 
II in the yeast cells that normally produce the N-
acetyltransferase can be compared with that in the yeast 
cells that produce reduced amount of the N-
acetyltransferase. This study may also provide valuable 
evidence for or against the view that N-acetylation of 
protein plays an important role in their in vivo stability. 
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FIGURE I 
THE SCHEME FOR ONE-STEP GENE DISRUPTION 
The cloned fragment containing GENE NAT is digested 
with a restriction enzyme that cleaves within the GENE NAT 
sequence. A fragment containing a selectable yeast gene, 
HIS3, is cloned into the site. The fragment containing the 
disrupted GENE NAT is liberated from plasmid sequences, 
making certain that homology to the GENE NAT region remains 
on both sides of the insert. Transformation of yeast cells 
with the linear fragment results in the substitution of the 
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